<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">44760</article-id><article-id pub-id-type="doi">10.7554/eLife.44760</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Structural basis of phosphatidylcholine recognition by the C2–domain of cytosolic phospholipase A<sub>2</sub>α</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-128797"><name><surname>Hirano</surname><given-names>Yoshinori</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9888-1616</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-128798"><name><surname>Gao</surname><given-names>Yong-Guang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9359-4252</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-128799"><name><surname>Stephenson</surname><given-names>Daniel J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5698-3400</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-128800"><name><surname>Vu</surname><given-names>Ngoc T</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-128814"><name><surname>Malinina</surname><given-names>Lucy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7973-1831</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-139251"><name><surname>Simanshu</surname><given-names>Dhirendra K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9717-4618</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-128804"><name><surname>Chalfant</surname><given-names>Charles E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5844-5235</contrib-id><email>cechalfant@usf.edu</email><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-14007"><name><surname>Patel</surname><given-names>Dinshaw J</given-names></name><email>pateld@mskcc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-128234"><name><surname>Brown</surname><given-names>Rhoderick E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7337-3604</contrib-id><email>reb@umn.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Structural Biology Program</institution><institution>Memorial Sloan-Kettering Cancer Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Graduate School of Biological Sciences</institution><institution>Nara Institute of Science and Technology (NAIST)</institution><addr-line><named-content content-type="city">Takayama</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Hormel Institute</institution><institution>University of Minnesota</institution><addr-line><named-content content-type="city">Austin</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution><institution>Virginia Commonwealth University Medical Center</institution><addr-line><named-content content-type="city">Richmond</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Cell Biology, Microbiology and Molecular Biology</institution><institution>University of South Florida</institution><addr-line><named-content content-type="city">Tampa</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Research Service</institution><institution>James A. Haley Veterans Hospital</institution><addr-line><named-content content-type="city">Tampa</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>The Moffitt Cancer Center</institution><addr-line><named-content content-type="city">Tampa</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Radhakrishnan</surname><given-names>Arun</given-names></name><role>Reviewing Editor</role><aff><institution>University of Texas Southwestern Medical Center</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wolberger</surname><given-names>Cynthia</given-names></name><role>Senior Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Laboratory of Protein Structural Biology, Graduate of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Frederick National Laboratory for Cancer Research, Frederick, United States</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>03</day><month>05</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e44760</elocation-id><history><date date-type="received" iso-8601-date="2018-12-28"><day>28</day><month>12</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2019-05-03"><day>03</day><month>05</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Hirano et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Hirano et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-44760-v3.pdf"/><abstract><p>Ca<sup>2+</sup>-stimulated translocation of cytosolic phospholipase A<sub>2</sub>α (cPLA<sub>2</sub>α) to the Golgi induces arachidonic acid production, the rate-limiting step in pro-inflammatory eicosanoid synthesis. Structural insights into the cPLA<sub>2</sub>α preference for phosphatidylcholine (PC)-enriched membranes have remained elusive. Here, we report the structure of the cPLA<sub>2</sub>α C2-domain (at 2.2 Å resolution), which contains bound 1,2-dihexanoyl-<italic>sn</italic>-glycero-3-phosphocholine (DHPC) and Ca<sup>2+</sup> ions. Two Ca<sup>2+</sup> are complexed at previously reported locations in the lipid-free C2-domain. One of these Ca<sup>2+</sup>ions, along with a third Ca<sup>2+</sup>, bridges the C2-domain to the DHPC phosphate group, which also interacts with Asn65. Tyr96 plays a key role in lipid headgroup recognition via cation–π interaction with the PC trimethylammonium group. Mutagenesis analyses confirm that Tyr96 and Asn65 function in PC binding selectivity by the C2-domain and in the regulation of cPLA<sub>2</sub>α activity. The DHPC-binding mode of the cPLA<sub>2</sub>α C2-domain, which differs from phosphatidylserine or phosphatidylinositol 4,5-bisphosphate binding by other C2-domains, expands and deepens knowledge of the lipid-binding mechanisms mediated by C2-domains.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>C2-domain of cytoplasmic phospholipase A2 alpha</kwd><kwd>structural mapping of phosphatidylcholine binding site</kwd><kwd>structure-function analyses</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Chicken</kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science, and Technology</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hirano</surname><given-names>Yoshinori</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL125353 (multi-PI)</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>Rhoderick E</given-names></name><name><surname>Chalfant</surname><given-names>Charles E</given-names></name><name><surname>Patel</surname><given-names>Dinshaw J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>U. S. Department of Veteran Affairs</institution></institution-wrap></funding-source><award-id>I BX001792</award-id><principal-award-recipient><name><surname>Chalfant</surname><given-names>Charles E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The C2-domain of cytoplasmic phospholipase A<sub>2</sub>α is structurally designed to target PC-rich membrane regions to increase the enzymatic efficiency of the catalytic domain, which prefers PCs with polyunsaturated acyl chains.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Lipids play indispensable roles in signal transduction, while also serving as essential structural components of the cell membrane, as energy resources, and as metabolites for the generation of hormones and eicosanoids. Phospholipase A<sub>2</sub> (PLA<sub>2</sub>) is a member of a diverse enzyme superfamily that hydrolyzes the <italic>sn-2</italic> acyl bond of glycerol-based phospholipids (<xref ref-type="bibr" rid="bib68">Smith, 1989</xref>; <xref ref-type="bibr" rid="bib20">Dennis et al., 2011</xref>). Cytosolic PLA<sub>2</sub>α (cPLA<sub>2</sub>α), a Group IV mammalian PLA<sub>2</sub> family member, preferentially releases arachidonic acid from PLs in a cytosolic Ca<sup>2+</sup>-concentration-dependent manner (<xref ref-type="bibr" rid="bib15">Clark et al., 1991</xref>; <xref ref-type="bibr" rid="bib64">Shimizu et al., 2006</xref>; <xref ref-type="bibr" rid="bib40">Leslie et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Vasquez et al., 2018</xref>). Arachidonic acid generated by cPLA<sub>2</sub>α is a precursor of pro-inflammatory eicosanoids, including certain prostaglandins and leukotrienes. Consequently, cPLA<sub>2</sub>-mediated bioactive lipid production plays a major regulatory role in physiological and pathogenic processes (<xref ref-type="bibr" rid="bib6">Bonventre et al., 1997</xref>; <xref ref-type="bibr" rid="bib74">Uozumi et al., 1997</xref>; <xref ref-type="bibr" rid="bib41">Leslie, 2015</xref>).</p><p>Insights into cPLA<sub>2</sub>α activation by regulatory mediators are of great importance because arachidonic acid release by cPLA<sub>2</sub>α at the membrane surface is the rate-limiting step in eicosanoid production. The ensuing prostaglandin and leukotriene production occurs via cyclooxygenases and lipoxygenases, respectively. Increases in intracellular Ca<sup>2+</sup> concentration that are induced by extracellular stimuli activate cPLA<sub>2</sub>α by inducing translocation from the cytoplasm to the perinuclear region, (i.e. the Golgi apparatus, nuclear envelope and endoplasmic reticulum) (<xref ref-type="bibr" rid="bib24">Evans et al., 2001</xref>). Mechanistically, the membrane translocation of cPLA<sub>2</sub>α is driven primarily by its N–terminal C2-domain rather than its catalytic domain (<xref ref-type="bibr" rid="bib50">Nalefski et al., 1994</xref>; <xref ref-type="bibr" rid="bib18">Davletov et al., 1998</xref>; <xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>). Complexation of two Ca<sup>2+</sup> ions by the C2-domain neutralizes several Asp residues, facilitating protein docking and penetration into the membrane interface region (<xref ref-type="bibr" rid="bib18">Davletov et al., 1998</xref>; <xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>; <xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>). Occupation of one Ca<sup>2+</sup>-binding site exerts stronger effects than occupation of the other in terms of stabilizing the membrane partitioning of the cPLA<sub>2</sub>α C2-domain (<xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>; <xref ref-type="bibr" rid="bib70">Stahelin and Cho, 2001a</xref>).</p><p>In addition to Ca<sup>2+</sup>, cPLA<sub>2</sub>α activators include specific lipids. Mutational functional analyses have revealed that ceramide-1-phosphate (C1P), a bioactive sphingolipid generated by ceramide kinase in the <italic>trans</italic>-Golgi, enhances enzyme translocation to perinuclear regions (<xref ref-type="bibr" rid="bib56">Pettus et al., 2004</xref>; <xref ref-type="bibr" rid="bib69">Stahelin et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Lamour et al., 2009</xref>) by binding directly to the C2-domain. Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P<sub>2</sub>) also activates cPLA<sub>2</sub>α, but independently of intracellular Ca<sup>2+</sup> concentration (<xref ref-type="bibr" rid="bib47">Mosior et al., 1998</xref>; <xref ref-type="bibr" rid="bib17">Das and Cho, 2002</xref>; <xref ref-type="bibr" rid="bib13">Casas et al., 2006</xref>), by binding a site that is enriched in cationic residues in the catalytic domain (<xref ref-type="bibr" rid="bib17">Das and Cho, 2002</xref>; <xref ref-type="bibr" rid="bib65">Six and Dennis, 2003</xref>; <xref ref-type="bibr" rid="bib73">Tucker et al., 2009</xref>). The cationic residue clusters that the cPLA<sub>2</sub>α C2-domain uses to bind C1P for membrane targeting (<xref ref-type="bibr" rid="bib69">Stahelin et al., 2007</xref>; <xref ref-type="bibr" rid="bib79">Ward et al., 2013</xref>) differ from those used by other C2-domains [e.g., protein kinase C (PKC), Syt and Rabphilin] that bind PI(4,5)P<sub>2</sub> (<xref ref-type="bibr" rid="bib33">Honigmann et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Guillén et al., 2013</xref>).</p><p>Structural insights into cPLA<sub>2</sub>α interaction with lipids are limited. NMR data have enabled the identification of several residues in the C2-domain calcium binding loops (CBLs) that interact with dodecylphosphocholine micelles (<xref ref-type="bibr" rid="bib82">Xu et al., 1998</xref>). Hydrogen-deuterium exchange mass spectrometry and molecular dynamic studies have also helped to map the membrane interaction regions of the C2-domain and have shed light on catalytic domain conformational accommodation of methyl arachidonoyl fluorophosphonate, a cPLA<sub>2</sub>α active-site inhibitor and 1-palmitoyl-2-arachidonoyl-<italic>sn</italic>-glycero-3-phosphocholine (PAPC) substrate (<xref ref-type="bibr" rid="bib10">Burke et al., 2008</xref>; <xref ref-type="bibr" rid="bib12">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mouchlis et al., 2015</xref>). Nonetheless, the lack of crystal structures for the cPLA<sub>2</sub>α C2-domain or for the cPLA<sub>2</sub>α catalytic domain containing bound phosphoglyceride has hampered understanding of the structural basis that underlies the lipid activation mechanism(s) and the known preference of cPLA<sub>2</sub> for phosphatidylcholine (PC)-enriched membranes.</p><p>Here, we report the X-ray crystal structure of the cPLA<sub>2</sub>α C2-domain bound to 1,2-dihexanoyl-<italic>sn</italic>-glycero-3-phosphocholine (DHPC). In contrast to the two bound Ca<sup>2+</sup> ions reported in the lipid-free structure (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>), we observed three Ca<sup>2+</sup> ions coordinated in the PC-bound structural complex, consistent with the established Ca<sup>2+</sup> dependence of membrane interaction by the C2-domain. Tyr96 is found to play a major role in the lipid recognition and selectivity of DHPC via cation–π interaction with the lipid’s trimethylammonium [N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub>] group. Two of the three bound Ca<sup>2+</sup> ions provide bridging interactions between the C2-domain and the DHPC phosphate group, which also interacts directly with Asn65. The DHPC-binding mode of the cPLA<sub>2</sub>α C2-domain differs substantially from that of the PKCα C2-domain or the Syt1 C2A-domain bound to phosphatidylserine (PS) or PI(4,5)P<sub>2</sub>, thereby expanding and deepening our knowledge of the lipid-binding mechanisms that are mediated by the C2-domain.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Overall structure of the cPLA<sub>2</sub> C2-domain bound to DHPC</title><p>To elucidate the mechanism of phosphoglyceride recognition by the C2-domain of cPLA<sub>2</sub>α, we initially attempted to generate complexes of the human recombinant protein with various lipids including PC, related phosphoglycerides and C1P analogs. Despite extensive crystallization trials, the resulting C2-domain crystals contained two bound Ca<sup>2+</sup> ions, but no bound lipid [as also reported by <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>]. However, using purified <italic>Gallus gallus</italic> (chicken) cPLA<sub>2</sub>α C2-domain (81% identical and 93% highly conserved sequence relative to human) (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we obtained crystal complexes with 1,2-dihexanoyl-<italic>sn</italic>-glycero-3-phosphocholine (DHPC) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), enabling structure determination at 2.2 Å resolution (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The electron density map for the entire C2-domain polypeptide chain is visible except for the N-terminal glycine, a cloning residue artifact. Notably, extra electron density corresponding to a bound DHPC molecule is found in the map (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), near the position reported for a bound MES [2-(N-morpholino) ethanesulfonic acid] buffer molecule in the structure of full-length human cPLA<sub>2</sub>α (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>). Three C2-domain molecules comprise the asymmetric unit and each C2-domain contains one bound DHPC molecule. The structures of the individual complexes are essentially the same. The C2-domain–DHPC complex exhibits a β-sandwich topology formed by a pair of four-stranded antiparallel β-sheets (one formed by the β4, β1, β8 and β7 strands; the other by the β3, β2, β5 and β6 strands) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Clearly resolved are the Ca<sup>2+</sup>-binding loops (CBL1, CBL2, and CBL3) formed by the β1–β2, β3–β4, and β5–β6 loops, respectively. CBL1 contains a short α-helix. The structure of the chicken C2-domain with bound DHPC is almost the same as that of human lipid-freeform (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>) with a small overall root mean square (r.m.s.) deviation of 0.7 Å after superimposition of Cα atoms (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Interestingly, we observed three bound Ca<sup>2+</sup> ions in the C2-domain–DHPC complex (<xref ref-type="fig" rid="fig1">Figure 1B, D and E</xref>), two of which correspond to the bound Ca1 and Ca4 in lipid-free human protein reported previously (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>). [Note: The <xref ref-type="bibr" rid="bib59">Rizo and Südhof, 1998</xref> numbering system is used for bound Ca<sup>2+</sup> in C2-domains (<xref ref-type="bibr" rid="bib16">Corbalan-Garcia and Gómez-Fernández, 2014</xref>).] We found that the Ca1 ion is bound via side-chain interactions with Asp40, Asp43, Asp93 and Asn95 and the main chain carbonyl group of Ala94; whereas Ca4 is bound via interaction with the side chains of Asp40, Asp43 and Asn65 and the main-chain carbonyl group of Thr41 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The Ca1 and Ca4 coordination networks are almost the same as those in the lipid-free structure (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>). Binding of the third Ca<sup>2+</sup> involves a stabilizing contact with Asn65 and interaction with the DHPC phosphoryl group. This Ca<sup>2+</sup> is designated Ca<bold><sup>PC</sup></bold> because of its novel location at CBL1, which is unique when compared with Ca<sup>2+</sup>-binding sites in various other C2-domains (<xref ref-type="bibr" rid="bib59">Rizo and Südhof, 1998</xref>; <xref ref-type="bibr" rid="bib16">Corbalan-Garcia and Gómez-Fernández, 2014</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Structure of cPLA<sub>2</sub>α C2‒domain containing bound DHPC and calcium.</title><p>(<bold>A</bold>) Sequence alignment of C2-domain calcium-binding loop (CBL) regions in cPLA2α from different eukaryotes compared to human PKCs and Syt1. Residues that bind Ca<sup>2+</sup> are green. Residues interacting directly with PC in our structural complex (blue or blue asterisk) are absolutely conserved among eukaryotic cPLA<sub>2</sub>α proteins but not in PKCs and Syt1. Conversely, residues that interact with PS in the PKCα-PS structure (magenta) are highly conserved in PKCs and Syt1, but not in cPLA<sub>2</sub>α. Shaded residues are identical. The human and chicken cPLA<sub>2</sub>α CBL sequences are 92% identical and 94.5% highly conserved (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> for full-length sequence alignment). (<bold>B</bold>) Ribbon structure representation of the cPLA<sub>2</sub>α C2-domain bound to 1,2-dihexanoyl-<italic>sn</italic>-glycero-3-phosphocholine (DHPC). The DHPC molecule (beige stick) straddles the β1–β2 loop (CBL1, blue), β3–β4 loop (CBL2, cyan) and β5–β6 loop (CBL3, red). Ca1 and Ca4 (blue spheres) are in a similar position in the apo-form structure; whereas Ca<sup>PC</sup> (magenta sphere) is unique to the DHPC-bound form. (<bold>C</bold>) DHPC structural formula. (<bold>D</bold>) <italic>F</italic>o-<italic>F</italic>c omit electron density map for the bound DHPC molecule at the 2.5σ contour level. (<bold>E</bold>) Superimposition of the chicken cPLA<sub>2</sub>α C2-domain with bound DHPC (colored as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>) on the human lipid-free structure (PDB: 1RLW, cyan). Root mean square deviation = 0.7 Å after superimposition of Cα atoms.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Sequence alignment of cPLA<sub>2</sub>α for human, mouse, and chicken proteins.</title><p>In the C2-Domains, Ca<sup>2+</sup> binding residues are cyan, DHPC binding residues are yellow; C1P binding residues are beige, and membrane interaction residues are burgundy. In the Catalytic Domains, active site residues are orange, PAPC polar headgroup interacting residues are blue, PAPC acyl chain interacting residues are lavender, PIP2 interacting residues are magenta, and phosphorylation sites are green. Sequence alignment was generated using Clustal W (<xref ref-type="bibr" rid="bib39">Larkin et al., 2007</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Tubular topology formed in the crystal lattice of the cPLA<sub>2</sub>α C2-domain–DHPC structural complex.</title><p>(Upper left panel) Cross-sectional view of three cPLA<sub>2</sub>α C2-PC complexes in the asymmetric unit (labeled A, B, C) and three complexes in the neighboring asymmetric unit (A*, B* and C*) that together form a ring-like structure. The hexanoyl acyl chains associated in one complex are separated from hexanoyl acyl chains in adjacent complexes by 4.9 to 7.2 Å. (Upper right panel) Rotation by 90° reveals PC lipids packed into a ring-like topology that forms a tubular-like scaffold. (Lower panel) The crystal packing lattice of lipid-free human cPLA<sub>2</sub>α C2-domain (PDB: 1RLW). The incorporated Ca<sup>2+</sup> is shown as blue spheres. Protomer A packs with protomers B and C, but not with protomer D.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig1-figsupp2-v3.tif"/></fig></fig-group><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Structural interactions of the cPLA<sub>2</sub>α C2-domain complexed with Ca<sup>2+</sup> and DHPC.</title><p>(<bold>A</bold>) Coordination of three bound Ca<sup>2+</sup> ions observed in the C2-domain–DHPC complex. Residues that interact with Ca<sup>2+</sup> ions are labeled in black with their side-chains (cyan) depicted in a stick representation. (<bold>B</bold>) Same view as in panel (A), but with PC-mediated interactions highlighted. Residues that interact directly with DHPC are labeled in red. (<bold>C</bold>) Space-filling view of bound DHPC and of Ca4 and Ca<sup>PC</sup> in the cPLA<sub>2</sub>α C2-domain. Darker gray residues (Y96, A94, H62, N64, and D43) provide contact surfaces for choline (cyan). Phosphorus is represented in orange; calcium in green; oxygen in red; and acyl carbons in beige. (<bold>D</bold>) Schematic summary of DHPC- and Ca<sup>2+</sup>-binding interactions with the cPLA<sub>2</sub>α C2-domain.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Zoomed views of the cPLA<sub>2</sub>α C2-domain complexed with Ca<sup>2+</sup> and DHPC.</title><p>C2-domain and DHPC are shown in lime green and beige, respectively. Nitrogen, oxygen, and phosphorus atoms are blue, red, and orange, respectively. Numeric labels for dashed lines equal distances in Ångstroms. Lower structure provides a ‘backside’ view (relative to the upper structure) by rotation 180° in the xy plane.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig2-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-2"><title>PC recognition</title><p>The DHPC polar headgroup docks with the CBLs, whereas the fatty acid chains are largely exposed to solvent. This orientation of bound PC in the complex is consistent with a function as an embedded membrane-anchoring element for the docking site of the protein. In the C2-domain–DHPC complex (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), the DHPC <italic>sn-</italic>2 chain is largely disordered except for the ester group, but nearly all of the <italic>sn</italic>-1 chain is observable because of the stabilizing interaction with Ca<bold><sup>PC</sup></bold> and the partial contact by Leu39 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The shorter fatty acid chains of DHPC compared to those of natural PCs may partially limit insights into the hydrophobic interactions mediated by fatty acid chains. Yet, it is noteworthy that the bulk of natural long-chain fatty acyl chains need not interact with the protein, but rather are expected to remain embedded in the bilayer to stabilize the PC headgroup docking sites in the membrane for cPLA<sub>2</sub>α C2-domains.</p><p>The DHPC phosphoryl group is positioned at the center of the CBLs, with the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group of DHPC directed towards CBL3 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The phosphoryl group is stabilized mainly by Ca<sup>2+</sup>-mediated bridging interactions. The only direct interaction between the phosphoryl group and the C2-domain is a hydrogen bond with the side chain of Asn65 (~3.1 Å) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Although Ca1 does not coordinate with the DHPC molecule, Ca4 does interact with two oxygen atoms of the DHPC phosphoryl group in bifurcated fashion (2.1 and 3.7 Å). Ca<bold><sup>PC</sup></bold>, which was not observed in two previous lipid-free structures (<xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>), bridges the C2-domain to DHPC via its phosphoryl group (3.6 Å) and <italic>sn</italic>-1 carbonyl group (3.2 Å) and also interacts with the Asn65 side-chain (3.1 Å) (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). Thus, Ca4 and Ca<bold><sup>PC</sup></bold> mediate both partial charge neutralization of the DHPC phosphoryl group, and by doing so, bridge the C2-domain and PC. The findings further elucidate the role played by bound Ca<sup>2+</sup> in mediating nonspecific membrane interaction while revealing direct interaction with PC. Zoomed views of the cPLA<sub>2</sub>α C2-domain complexed with Ca<sup>2+</sup> and DHPC are provided in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and associated interaction distances are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Interaction distances in cPLA<sub>2</sub>α C2-domain. </title><p>Interaction distances (Å) associated with bound calcium in the lipid-free cPLA<sub>2</sub>α C2-domain structure (2.4 Å resolution; PDB 1RLW) of <xref ref-type="bibr" rid="bib55">Perisic et al. (1998)</xref> and with bound calcium and DHPC in the C2-domain–DHPC crystal complex (2.2 Å resolution) of the present study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"><bold>1RLW</bold></th><th colspan="2" valign="top">Ca1</th><th valign="top">Ca4</th></tr></thead><tbody><tr><td align="left" valign="top"> Asp40</td><td colspan="2" valign="top">2.3/3.4</td><td valign="top">2.3</td></tr><tr><td align="left" valign="top"> Asp43</td><td colspan="2" valign="top">2.1</td><td valign="top">2.6/2.2</td></tr><tr><td align="left" valign="top"> Asp93</td><td colspan="2" valign="top">2.7/2.5</td><td valign="top"/></tr><tr><td align="left" valign="top"> Asn65</td><td colspan="2" valign="top"/><td valign="top">2.1</td></tr><tr><td align="left" valign="top"> Asn95</td><td colspan="2" valign="top">2.2</td><td valign="top"/></tr><tr><th align="left" rowspan="2" valign="middle"><bold>C2/DHPC</bold></th><th align="center" colspan="4" valign="top">C2﻿ </th><th colspan="6" valign="top">DHPC</th></tr><tr><th valign="top">Ca1</th><th colspan="2" valign="top">Ca4</th><th valign="top">Ca<sup>PC</sup></th><th valign="top">N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub></th><th valign="top">PO<sub>4</sub></th><th valign="top"><italic>sn</italic>-2 C=O</th><th valign="top"><italic>sn</italic>-1 C=O</th><th colspan="2" valign="top"><italic>sn</italic>-1 chain</th></tr><tr><td align="left" valign="top"> Asp40</td><td valign="top">2.4/3.4</td><td colspan="2" valign="top">2.4</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Asp43</td><td valign="top">2.3</td><td colspan="2" valign="top">2.6/2.7</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Asp93</td><td valign="top">2.7/2.8</td><td colspan="2" valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Asn65</td><td valign="top"/><td colspan="2" valign="top">2.4</td><td valign="top">3.1</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Asn95</td><td valign="top">2.3</td><td colspan="2" valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Tyr96</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">~4.0</td><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Ala94</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">3.6</td><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> His62</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">~5.0</td><td valign="top">~8.5</td><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Asn64</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">3.6</td><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Leu39</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td colspan="2" valign="top">5.4</td></tr><tr><td align="left" valign="top"> Ca1</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">5.5</td><td valign="top">5.7</td><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Ca4</td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">6.3</td><td valign="top">2.1</td><td valign="top"/><td valign="top"/><td colspan="2" valign="top"/></tr><tr><td align="left" valign="top"> Ca<sup>PC</sup></td><td valign="top"/><td colspan="2" valign="top"/><td valign="top"/><td valign="top">8.5</td><td valign="top">3.6</td><td valign="top">3.2</td><td valign="top">3.1</td><td colspan="2" valign="top"/></tr></tbody></table></table-wrap><p>The -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group of DHPC is partially surrounded by Tyr96 of CBL3 and His62 and Asn64 of CBL2 (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). Importantly, the Tyr96 aromatic ring stacks in planar-like fashion with the cationic -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group. This kind of electrostatic interaction, that is cation-π interaction, occurs at distances of less than 6.0 Å between a positively charged atom or group and the flat face of an aromatic ring that has a partial negative charge due to delocalized π electrons (<xref ref-type="bibr" rid="bib22">Dougherty, 2013</xref>; <xref ref-type="bibr" rid="bib26">Gallivan and Dougherty, 1999</xref>). The position of the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group is further stabilized by van der Waals contacts with the Ala94 methyl group and by a possible weak (off-angle) cation-π interaction with the His62 imidazole ring (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). The orientation of His62 appears to be affected by hydrogen bonding (2.8 Å) between its imidazole group and the side-chain carbonyl group of Asn64, which also interacts (weakly) with the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group. Notably, in the structure of the lipid-free C2-domain (<xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>), a cadmium ion from the crystallization buffer was localized between Tyr96 and His62, consistent with cation-π interaction (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Previous mutational analyses support His62 interaction with PC as well as a more significant role for this residue in binding C1P (<xref ref-type="bibr" rid="bib79">Ward et al., 2013</xref>). In other proteins that specifically bind PC, such as the PC transfer protein, cation–π interactions involving Tyr and Trp are determinants of PC specificity (<xref ref-type="bibr" rid="bib60">Roderick et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Kang et al., 2010</xref>).</p><p>In our study, DHPC binding induced no major conformational changes in the C2-domain CBLs. Notably, NMR studies of the cPLA<sub>2</sub>α C2-domain depict the Tyr96 indole ring in an outward position when not interacting with dodecylphosphocholine micelles (<xref ref-type="bibr" rid="bib82">Xu et al., 1998</xref>). Thus, PC binding could require local conformational changes, such as inward flipping of Tyr96, to optimize π–cation interaction for complex formation.</p></sec><sec id="s2-3"><title>Functional mutagenesis analyses of PC-interacting residues in the cPLA<sub>2</sub>α C2-domain</title><p>The central importance of Tyr96 for PC selectivity is supported by functional mutagenesis of the C2-domain residues observed interacting with DHPC. The Y96A point mutant, which is unable to undergo cation–π interaction with the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group of DHPC, exhibited significantly reduced affinity for PC bilayer vesicles when compared to either the conservatively mutated Y96F (which supports strong cation-π interaction) or the control C2–domain, as shown by SPR (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). Also, disruption of the PC phosphate group interaction with N65 by point mutation to Asp (N65D) significantly reduced partitioning to PC vesicles (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). In previous surface plasmon resonance (SPR) and DHPC-coated bead studies involving a refolded C2-domain containing a 20-residue affinity tag including 6xHis (<xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>; <xref ref-type="bibr" rid="bib71">Stahelin and Cho, 2001b</xref>; <xref ref-type="bibr" rid="bib78">Ward et al., 2012</xref>), weaker affinity of Y96A and D65A mutants for DHPC was observed. In our experiments, the Ca<sup>2+</sup>-concentration-dependence of the process that drives C2-doman point mutants (Y96A, Y96F, and N65D) to PC membranes was assessed by Förster resonance energy transfer (FRET) between Trp71 of the C2-domain and dansyl-PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(5-dimethylamino-1-naphthalenesulfonyl) in the PC model membranes (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The need for greater Ca<sup>2+</sup> concentrations to induce Y96A or N65D partitioning to the PC model membranes compared to either Y96F or control C2-domain partitioning, was clearly evident. <xref ref-type="fig" rid="fig3">Figure 3C</xref> shows additional FRET data obtained by titration of the C2-domain mutants with increasing amounts of PC model membranes at constant Ca<sup>2+</sup> concentration (50 µM). The summarized data (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) confirm the weaker PC-binding affinity of the Y96A and N65D mutants compared to the Y96F mutant or the control C2-domain.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Membrane partitioning of cPLA<sub>2</sub>α C2-domains and cPLA<sub>2</sub>α catalytic activities of point-mutated C2-domains in the PC-binding region.</title><p>(<bold>A</bold>) SPR binding isotherms showing point mutant and control protein equilibrium adsorption to immobilized 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC) vesicles saturating a L1 sensor chip at 5 μl/min solution flow rates (see 'Materials and methods'). (<bold>B</bold>) FRET binding isotherms showing the Ca<sup>2+</sup> dependence of point mutant and control protein (0.5 μM) equilibrium adsorption to POPC–DHPC bicelle-dilution vesicles (4 μM) (see 'Materials and methods'). (<bold>C</bold>) FRET-binding isotherms showing the POPC–DHPC bicelle-dilution vesicle dependence of point mutant and control protein (0.5 μM) equilibrium adsorption at 50 μM Ca<sup>2+</sup> (see 'Materials and methods'). (<bold>D</bold>) Relative binding affinity of C2-domain point mutants and control protein obtained for binding isotherms shown in panel (C). (<bold>E</bold>) Effect of the Y96F, Y96A, N64A, and N65D mutations on the dissociation constant (K<sub>s</sub><sup>A</sup>) of human cPLA<sub>2</sub>α activity. Proteins were purified as described <xref ref-type="bibr" rid="bib69">Stahelin et al. (2007)</xref>. Activity was measured as a function of PC molar concentration for 60 min at 37°C. The PC mole fraction was held constant at 0.285. cPLA<sub>2</sub>α activities (nmol of arachidonic acid released/min/mg of recombinant cPLA<sub>2</sub>α) were collected on eight separate occasions and are presented as n = 4 for Y96F, n = 4 for Y96A, n = 4 for N64A, n = 4 for N65D, and n = 8 for WT. Error = standard deviation. R<sup>2</sup> values are 0.9021, 09609, 0.9586, 0.9780, and 0.9485 for WT, Y96F, Y96A, N64A, and N65D, respectively. (<bold>F</bold>) Effect of Y96F, Y96A, N64A, and N65D mutations on the allosteric sigmoidal constant (K<sub>half</sub>) of human cPLA<sub>2</sub>α activity. Activity was measured as a function of increasing PC mole fractions for 60 min at 37°C. The PC mole fraction ([PC]/[PC]+[TX-100]) was 0.024 at 50 μM PC, 0.047 at 100 μM PC, 0.069 at 150 μM, 0.091 at 200 μM, 0.13 at 300 μM PC, 0.166 at 400 μM, 0.2 at 500 μM PC, 0.28 at 800 μM PC, 0.37 at 1200 μM PC, and 0.44 at 1600 μM PC. cPLA<sub>2</sub>α activities (nmol of arachidonic acid released/min/mg of recombinant cPLA<sub>2</sub>α) were collected on ten separate occasions and are presented as n = 4 for Y96F, n = 4 for Y96A, n = 4 for N64A, n = 4 for N65D, and n = 4 for WT. Error = standard deviation. R<sup>2</sup> values are 0.9413, 0.9577, 0.9407, 0.9376, and 0.9761 for WT, Y96F, Y96A, N64A, and N65D, respectively.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Membrane partitioning data for cPLA<sub>2</sub>α C2-domains mutated in PC binding region.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-44760-fig3-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Activity data for cPLA<sub>2</sub>α C2-domains mutated in PC binding region.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-44760-fig3-data2-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig3-v3.tif"/></fig><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title><italic>K</italic><sub>d</sub> values determined by SPR.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein</th><th><italic>K</italic><sub>d</sub> (M)</th><th valign="top">Fold increase<sup>*</sup></th></tr></thead><tbody><tr><td>WT-C2-domain</td><td>(4.2 ± 0.8)×10<sup>−7</sup></td><td valign="top">----</td></tr><tr><td>Y96F-C2-domain</td><td>(4.3 ± 0.5)×10<sup>−7</sup></td><td valign="top">1</td></tr><tr><td valign="top">Y96A-C2-domain</td><td valign="top">(2.4 ± 0.4)×10<sup>−6</sup></td><td valign="top">5.7</td></tr><tr><td>N65D-C2-domain</td><td>(2.2 ± 0.5)×10<sup>−6</sup></td><td valign="top">5.2</td></tr></tbody></table><table-wrap-foot><fn><p> <sup>*</sup>Fold increase in K<sub>d</sub> relative to the C2-domain binding to POPC vesicles. K<sub>d</sub> values were determined from the normalized saturation binding responses (R<sub>eq</sub>) at the protein concentrations shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> after fitting by nonlinear least squares analysis using R<sub>eq</sub> = R<sub>max</sub>/(1 + K<sub>d</sub>/C).</p></fn></table-wrap-foot></table-wrap><p>Since the preceding mutational analyses focused on the role of PC-interacting residues in isolated C2-domain on protein binding to PC membranes, the functional impact of these same mutations on the catalytic activity of cPLA<sub>2</sub>α (C2-domain + catalytic domain) was also determined using established mixed-micelle assays (<xref ref-type="bibr" rid="bib81">Wijesinghe et al., 2009</xref>). By using surface dilution kinetics and tracking the total mass of arachidonic acid release from 1-palmitoyl- 2-arachidonoyl-<italic>sn</italic>-glycero-3-phosphocholine (PAPC) via UPLC-MS/MS, protein interfacial partitioning and enzymatic activity were analyzed (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>, <xref ref-type="table" rid="table2">Table 2 and 3</xref>). Notably, the data support the functional importance of Tyr96 for PC association. Specifically, the association of the Y96A mutant with PAPC-containing mixed micelles is significantly reduced, that is , the dissociation rate is increased as signified by an increased Ks<sup>A</sup>, compared to that of either the conservative Y96F point mutant or the control enzyme (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; <xref ref-type="table" rid="table2">Table 2</xref>). Also, the turnover of the Y96A mutant enzyme displayed allosteric sigmoidal kinetics once the enzyme was bound to the surface of micelles containing PAPC (e.g., a significant difference in V<sub>max</sub> was observed) without significantly affecting K<sub>0.5</sub>(i.e., the PAPC concentration that produces half-maximal enzyme velocity) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="table" rid="table3">Table 3</xref>). These data indicate that Tyr96 is key for recognizing and binding PC in the membrane but not for the enzymatic activity of the catalytic domain towards substrate once the enzyme is associated with the membrane.</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Kinetic activity parameters for point-mutated PC-binding-site residues in the C2-domain of cPLA<sub>2</sub>α*.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Protein</th><th valign="top">Ks<sup>A </sup>(μM)</th><th valign="top"><bold>V<sub>max</sub></bold> (nmol/min/mg)</th></tr></thead><tbody><tr><td valign="top">WT-cPLA<sub>2</sub>α</td><td valign="top">182.8 ± 12.5</td><td valign="top">4.053 ± 0.092</td></tr><tr><td valign="top">Y96F-cPLA<sub>2</sub>α</td><td valign="top">205.8 ± 12.7</td><td valign="top">4.930 ± 0.111</td></tr><tr><td valign="top">Y96A-cPLA<sub>2</sub>α</td><td valign="top">467.5 ± 31.6</td><td valign="top">3.438 ± 0.177</td></tr><tr><td valign="top">N65D-cPLA<sub>2</sub>α</td><td valign="top">394.9 ± 29.8</td><td valign="top">3.203 ± 0.166</td></tr><tr><td valign="top">N64A-cPLA<sub>2</sub>α</td><td valign="top">207.7 ± 9.63</td><td valign="top">4.328 ± 0.069</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Analyses for data shown in <xref ref-type="fig" rid="fig3">Figure 3E</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Kinetic activity parameters for point-mutated PC-binding-site residues in the C2-domain of cPLA<sub>2</sub>α *</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Protein <break/><break/></th><th valign="top"><bold>K<sub>0.5</sub></bold> <break/>(mole fraction)</th><th valign="top"><bold>V<sub>max</sub></bold> <break/>(nmol/min/mg)</th></tr></thead><tbody><tr><td valign="top">WT-cPLA<sub>2</sub>α</td><td valign="top">0.130 ± 0.007</td><td valign="top">4.352 ± 0.183</td></tr><tr><td valign="top">Y96F-cPLA<sub>2</sub>α</td><td valign="top">0.132 ± 0.007</td><td valign="top">4.362 ± 0.172</td></tr><tr><td valign="top">Y96A-cPLA<sub>2</sub>α</td><td valign="top">0.139 ± 0.006</td><td valign="top">2.510 ± 0.098</td></tr><tr><td valign="top">N65D-cPLA<sub>2</sub>α</td><td valign="top">0.143 ± 0.005</td><td valign="top">1.791 ± 0.050</td></tr><tr><td valign="top">N64A-cPLA<sub>2</sub>α</td><td valign="top">0.142 ± 0.008</td><td valign="top">3.436 ± 0.168</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Analyses for data shown in <xref ref-type="fig" rid="fig3">Figure 3F</xref></p></fn></table-wrap-foot></table-wrap><p>In cPLA<sub>2</sub>α, disruption of the N65 interaction with the PC phosphate group by point mutation to Asp (N65D) also significantly reduced the association with micelles containing PAPC when compared to the same interaction for the WT enzyme and the N64A mutant (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; <xref ref-type="table" rid="table2">Table 2</xref>), in agreement with the SPR and FRET findings for purified C2-domain mutants. Notably, however, the reduced V<sub>max</sub> observed for N65D cPLA<sub>2</sub>α, alongside the lack of a significant effect on the enzyme's affinity for substrate, K<sub>0.5</sub> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="table" rid="table3">Table 3</xref>), suggests a possible role in enzyme lateral diffusion (i.e., ‘scooting’) once bound to the membrane. Of note, N64 replacement with Ala (N64A) had no significant effect on either the dissociation rate or the kinetic parameters of the enzyme. Overall, the mutagenesis data strongly support the key role played by both Y96 and N65 in recognizing and binding to PC-rich membranes, with N65 and Y96 regulating PC-binding affinity and playing a potential role in the enzyme’s ability to ‘scoot’ while bound to the membrane and thus to cleave substrate, as previously modeled by Gelb and co-workers (<xref ref-type="bibr" rid="bib4">Bayburt and Gelb, 1997</xref>).</p></sec><sec id="s2-4"><title>Lipid specificity of the cPLA<sub>2</sub>α C2-domain</title><p>To further evaluate the apparent preference of the cPLA<sub>2</sub>α C2-domain for PC, SPR analyses were carried out using phosphoglycerides with different polar headgroups (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The relative binding affinity of the C2-domain for POPC was found to be ~5 fold greater than that for chain-matched phosphatidylserine (POPS), phosphatidic acid (POPA), phosphatidylglycerol (POPG), or phosphatidylinositol (POPI) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). With phosphatidylethanolamine (POPE), lipid adsorption to the SPR L1 Sensor Chip was quite low compared to that of the other phospholipids. To circumvent this issue, 30 mole% POPE was co-mixed with either POPC or POPS. No significant change was found for C2-domain binding to POPC vesicles containing POPE or POPS compared to binding to pure POPC vesicles, showing the dominating effect of the PC headgroup. Yet, C2-domain binding to the POPS vesicles was slightly improved by 30 mole% POPE (see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Our single phosphoglyceride SPR results agree with previous FRET studies (Trp to dansyl-PE) in which binding to lipid vesicles was assessed using a slightly longer, re-folded, recombinant, human cPLA<sub>2</sub>α C2-domain (<xref ref-type="bibr" rid="bib51">Nalefski et al., 1998</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>cPLA<sub>2</sub>α C2-domain binding affinity for phosphoglyceride and sphingomyelin (SM) vesicles.</title><p>(<bold>A</bold>) Phosphoglyceride structural formulas. (<bold>B</bold>) Relative affinities of the C2-domain (1 μM) for different phosphoglycerides obtained by SPR. Molar ratios for PS/PE, PC/PS and PC/PE mixed composition vesicles are 7:3. (see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). (<bold>C</bold>) SPR binding isotherms showing C2-domain equilibrium adsorption to immobilized POPC or 18:1-SM vesicles as a function of protein concentration (see <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> for additional information). (<bold>D</bold>) Effect of C2-domain mutations (1 μM) on binding to 18:1 SM obtained by SPR (see 'Materials and methods' for other details).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>cPLA<sub>2</sub>α C2-domain binding affinity for phosphoglyceride and sphingomyelin (SM) vesicles.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-44760-fig4-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Assessment of C2-domain binding to different phosphoglycerides.</title><p>Head group chemical formulas of various non-PC membrane phosphoglycerides are (<bold>A</bold>) phosphatidylethanolamine, PE; (<bold>B</bold>) phosphatidylserine, PS; (<bold>C</bold>) phosphatidylglycerol, PG; (<bold>D</bold>) phosphatidylinositol, PI; and (<bold>E</bold>) phosphatidic acid, PA. All of the phosphoglycerol-based lipids have the same backbone topology but different head groups that define C2-domain binding specificity. Our findings reveal that the π-cation interaction is critical for binding to PC. PE (<bold>A</bold>) has a primary ammonium group replacing the –N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group in PC. Yet, earlier FRET data (<xref ref-type="bibr" rid="bib51">Nalefski et al., 1998</xref>) and our SPR data (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) indicate relatively weak binding of cPLA<sub>2</sub>α C2-domain to PE. The electrostatic potential difference and diminished van der Waals contacts with Ala94, His62, and Asn64 could account for the binding affinity decrease for PE compared to PC. PS has a seryl group (<bold>B</bold>) replacing the –N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group in PC. Although the primary ammonium group in the seryl group would seem to be a candidate for undergoing π-cation interaction with Tyr96, binding by C2-domain is weak (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) suggesting steric clashing of the seryl carboxylate group with CBL residues. PG (<bold>C</bold>) and PI (<bold>D</bold>) are not suitable for interaction with cPLA<sub>2</sub>α C2-domain due to lack of an ammonium group and steric clashing by their bulky head groups. PA (<bold>E</bold>) has only a phosphoryl moiety as its head group, which promotes weak interaction. Our SPR binding data showing much weaker binding of these phosphoglyerides compared to PC (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) are consistent with previous findings obtained using other techniques (<xref ref-type="bibr" rid="bib47">Mosior et al., 1998</xref>; <xref ref-type="bibr" rid="bib51">Nalefski et al., 1998</xref>; <xref ref-type="bibr" rid="bib65">Six and Dennis, 2003</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig4-figsupp1-v3.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The concentration- and time-dependence of C2-domain adsorption/desorption to/from immobilized POPC and 18:1 SM vesicles measured by SPR.</title><p>(<bold>Upper panel</bold>) SPR data showing cPLA<sub>2</sub>α C2-domain adsorption/desorption to/from immobilized POPC vesicles at varying protein concentrations (0.1, 0.2, 0.4, 0.6, 1, 2, and 4 μM; bottom to top) and 5 μl/min flow rate. The two-headed arrow indicates switch to buffer containing no protein. The same approach was used to assess C2-domain adsorption to immobilized 18:1-SM vesicles shown in <xref ref-type="fig" rid="fig4">Figure 4C and 4D</xref>. The <italic>K</italic>d values calculated from the binding isotherms for C2-domain and the point mutants are reported in <xref ref-type="table" rid="table1">Table 1</xref>. (<bold>Lower panel</bold>) SPR data showing the time-dependence for cPLA<sub>2</sub>α C2-domain adsorption/desorption to/from immobilized 18:1 SM vesicles at 0.6 μM protein concentration.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig4-figsupp2-v3.tif"/></fig></fig-group><p>Because of the proposed preference of the cPLA<sub>2</sub>α C2-domain for the PC headgroup, we evaluated C2-domain binding to sphingomyelin (SM), which also has a phosphorylcholine headgroup (<xref ref-type="bibr" rid="bib51">Nalefski et al., 1998</xref>; <xref ref-type="bibr" rid="bib42">Leslie and Channon, 1990</xref>; <xref ref-type="bibr" rid="bib35">Klapisz et al., 2000</xref>; <xref ref-type="bibr" rid="bib49">Nakamura et al., 2010</xref>). An issue in need of clarification is whether the reported inhibition of cPLA<sub>2</sub>α activity by SM arises from diminished membrane binding driven by the C2-domain or simply because of the inability of the cPLA<sub>2</sub>α esterase (i.e., catalytic domain) to hydrolyze SM after binding to the membrane. Using SPR, we detected significantly weaker binding affinity of C2–domain for vesicles composed of <italic>N</italic>–oleoyl SM (<italic>K</italic><sub>d</sub> = 0.93 ± 0.28 x 10<sup>−5</sup>) compared to POPC (<italic>K</italic><sub>d</sub> = 4.2 ± 0.8 x 10<sup>−7</sup>), despite the shared phosphorylcholine headgroup and the presence of 50 μM CaCl<sub>2</sub> (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Notably, SPR measurements involving the Y96F, Y96A, and N65D mutants revealed similar <italic>relative</italic> decreases in binding to 18:1-SM vesicles compared to POPC vesicles (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These findings support the key involvement of Tyr96 and Asn65 in binding the phosphorylcholine headgroup of SM but indicate that other factors contribute to the weaker binding of the cPLA<sub>2</sub>α C2-domain to SM compared to PC.</p><p>It is noteworthy that <italic>N</italic>-oleoyl SM was used for comparison with POPC to avoid effects related to lipid-packing differences of bilayer liquid-crystalline versus gel phase states and to provide relatively well-matched aliphatic chains (18:1-SM vs POPC). Nonetheless, the known propensity of SM for intra- and inter-molecular hydrogen bonding enables more self-interaction than is possible for POPC even when both lipids are in similar bilayer phase states (<xref ref-type="bibr" rid="bib67">Smaby et al., 1996</xref>; <xref ref-type="bibr" rid="bib9">Brown and Brockman, 2007</xref>; <xref ref-type="bibr" rid="bib83">Zhai et al., 2014</xref>; <xref ref-type="bibr" rid="bib66">Slotte, 2016</xref>). The net effect for SM is not only moderately tighter lateral packing in bilayers (compared to POPC) but a phosphorylcholine headgroup with altered conformation and restricted orientational freedom that may partially mitigate interaction with C2-domain binding site residues.</p><p>Another important parameter that can affect protein behavior at the membrane interface is the dipole potential that arises from the oriented lipid polar functional groups and associated water molecules located in the interfacial region separating the aqueous phase and hydrocarbon-like interior of the membrane (<xref ref-type="bibr" rid="bib7">Brockman, 1994</xref>; <xref ref-type="bibr" rid="bib46">McIntosh et al., 1992</xref>; <xref ref-type="bibr" rid="bib8">Brockman et al., 2004</xref>). Because of structural differences in the lipid backbones (glycerol with esterified acyl chains in POPC versus sphingosine with an amide-linked acyl chain in SM) (<xref ref-type="fig" rid="fig1">Figure 1C and 4C</xref>), their dipole potentials differ by ~90 to 240 mV (depending on lipid phase state). This difference has been traced to the similar positioning of the carbonyl group in the esterified fatty acyl chain of POPC and the 3-OH group in the SM sphingoid chain (<xref ref-type="bibr" rid="bib46">McIntosh et al., 1992</xref>). Given the importance of the bilayer dipole potential in the regulation of amphitropic protein and drug translocation to the membrane interface (<xref ref-type="bibr" rid="bib2">Alakoskela et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Brockman, 1994</xref>; <xref ref-type="bibr" rid="bib36">Kovács et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Richens et al., 2015</xref>), the lower dipole potential of SM appears to be a probable contributor to the weaker interaction of the cPLA<sub>2</sub>α C2-domain for SM bilayers.</p><p>The structure of the C2-domain–DHPC complex also reveals the role played by the PC <italic>sn-1</italic> ester linkage and associated carboxyl moiety (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) interacting with the Ca<bold><sup>PC</sup></bold> ion. Although the structurally equivalent amide-acyl linkage in SM (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) could interact with the Ca<bold><sup>PC</sup></bold> ion, the weaker electronegativity of the carbonyl group in the amide linkage (compared to an ester linkage) may contribute to the diminished binding affinity. Regardless, it is noteworthy that the cPLA<sub>2</sub>α association with SM-enriched membranes will not enable SM hydrolysis because cPLA<sub>2</sub>α is an esterase and its catalytic domain can hydrolyze neither the sphingoid chain nor the amide-linked acyl chain in SM. Our SPR data showing 4-to 5-fold weaker C2-domain binding to SM vesicles than to POPC clarify somewhat conflicting earlier findings regarding the molecular basis for SM inhibition of cPLA<sub>2</sub>α action (<xref ref-type="bibr" rid="bib51">Nalefski et al., 1998</xref>; <xref ref-type="bibr" rid="bib49">Nakamura et al., 2010</xref>). Notably, despite the weak affinity of the cPLA<sub>2</sub>α C2-domain for SM, in vivo inhibition of activity is unlikely because of intracellular topological factors. cPLA<sub>2</sub>α translocates to the Golgi cytosolic face to function; whereas SM is synthesized at the Golgi lumen before being exported to the plasma membrane (<xref ref-type="bibr" rid="bib72">Tafesse et al., 2007</xref>; <xref ref-type="bibr" rid="bib19">Deng et al., 2016</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>C2-domains occur in many (&gt;127) eukaryotic proteins. The C2-domain superfamily includes two families: i) PLC-like variants (including cPLA<sub>2</sub>α), known as the P-family or type II topology and ii) synaptotagmin (Syt)-like variants referred to as the S-family or type I topology, based on their circularly permuted topologies that generate a different orientation of their eight β-strands (<xref ref-type="bibr" rid="bib16">Corbalan-Garcia and Gómez-Fernández, 2014</xref>). In both C2-domain families, Ca<sup>2+</sup> ions bind acidic residues within Ca<sup>2+</sup> binding loops that converge at one end of the β-sandwich structure. The resulting electrostatic neutralization serves as molecular glue to bridge the C2–domain to the phosphoglyceride membrane. Previous analyses of the cPLA<sub>2</sub>α C2-domain D93N and N65A mutants, which have defects in the Ca1 and Ca4 sites, respectively, indicate that occupation of the Ca1 site is more essential for membrane binding and activity, perhaps because of favorable conformational changes in the nonpolar residue aliphatic and aromatic side-chains of CBL3 that stabilize membrane interaction (<xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>; <xref ref-type="bibr" rid="bib70">Stahelin and Cho, 2001a</xref>). Other mutational studies have shown the key role played by various nonpolar residues located in the CBLs in membrane docking and insertion by the C2-domain upon Ca<sup>2+</sup> binding and neutralization of nearby anionic Asp residues (<xref ref-type="bibr" rid="bib50">Nalefski et al., 1994</xref>; <xref ref-type="bibr" rid="bib18">Davletov et al., 1998</xref>; <xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>; <xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>; <xref ref-type="bibr" rid="bib65">Six and Dennis, 2003</xref>; <xref ref-type="bibr" rid="bib10">Burke et al., 2008</xref>; <xref ref-type="bibr" rid="bib70">Stahelin and Cho, 2001a</xref>; <xref ref-type="bibr" rid="bib71">Stahelin and Cho, 2001b</xref>; <xref ref-type="bibr" rid="bib52">Nalefski and Falke, 1998</xref>; <xref ref-type="bibr" rid="bib3">Ball et al., 1999</xref>; <xref ref-type="bibr" rid="bib44">Malmberg et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">Malmberg and Falke, 2005</xref>; <xref ref-type="bibr" rid="bib43">Málková et al., 2005</xref>). For instance, studies of F35A, M38A, L39A in CBL1 as well as Y96A, V97A, and M98A in CBL3 support their involvement in the interaction with DHPC-coated beads and their importance for optimal cPLA<sub>2</sub>α activity (<xref ref-type="bibr" rid="bib5">Bittova et al., 1999</xref>). Several of these earlier biophysical studies have provided detailed insights into general aspects of membrane interaction involving the cPLA<sub>2</sub>α C2-domain. Not previously addressed, however, was the possibility that the cPLA<sub>2</sub>α C2-domain is structurally designed to target PC-rich membrane regions, thereby helping to increase the enzymatic efficiency of the catalytic domain, which prefers PCs carrying polyunsaturated acyl chains. The current study reveals the molecular basis through which Ca4 and Ca<sup>PC</sup>, as well as Tyr96, Ala94, Asn64, Asn65, and Leu39, work together to target lipids containing phosphorylcholine headgroups (such as PC and SM) whereas other nonpolar residues (Phe35, Met38, Met98, and Val97) appear to promote more nonspecific interactions with the phosphoglyceride bilayer.</p><p>The molecular details provided by our structure-function data on DHPC binding with the cPLA<sub>2</sub>α C2-domain provide further insight into the C2-domain's penetration of the membrane interface. <xref ref-type="fig" rid="fig5">Figure 5A</xref> depicts an <italic>ad hoc</italic> model showing the interaction of the C2-domain–DHPC complex with a PC membrane interface, within the context of an earlier docking and penetration model associated with a more general membrane interaction by the cPLA<sub>2</sub>α C2-domain (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In addition, we consider structural parameters determined for liquid-crystalline (Lα phase) bilayers consisting of di-oleoyl PC (<xref ref-type="bibr" rid="bib80">Wiener and White, 1992</xref>). Such parameters include the distances of choline (21.87 Å), phosphate (20.17 Å), and the acyl chain carbonyl groups (15.98 Å) from the bilayer mid-plane, as well as the nitrogen–phosphate distance (4.5 Å) within phosphorylcholine, which orients at 22 ± 4° with respect to the bilayer surface. Using the acyl carbonyl groups as markers of the headgroup-hydrocarbon boundary (<xref ref-type="bibr" rid="bib80">Wiener and White, 1992</xref>), the polar headgroup region thickness equals ~8.5–9.0 Å (based on ~5.9 Å for the acyl carbonyl group to choline nitrogen, when allowing plus 2.5–3.0 Å for the hydration of choline). In the C2-domain–DHPC crystal complex, slightly larger distances are observed, such as 6.9 Å for <italic>sn</italic>-2 carbonyl to choline nitrogen and 4.7 Å for the nitrogen-to-phosphate distance. Membrane penetration depths estimated from the crystal structure data for CBL3 Val97 and for CBL1 Ile39 are 10–10.5 Å and 12–12.5 Å, respectively, which are comparable with previous data (<xref ref-type="bibr" rid="bib44">Malmberg et al., 2003</xref>) and which represent a ~78–85% penetration depth relative to the mid-plane of a fluid bilayer (<xref ref-type="bibr" rid="bib80">Wiener and White, 1992</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Model of the cPLA<sub>2</sub>α C2-domain selectively interacting with the PC membrane interface.</title><p>(<bold>A</bold>) Interaction of the C2-domain–DHPC structural complex with a PC membrane interface produced by <italic>ad hoc</italic> modeling. The dashed horizontal lines represent planar boundaries for the lipid headgroup and hydrocarbon regions of the PC bilayer. The crystal structure of the C2-domain–DHPC complex is represented as pale green ribbon. The Ca<sup>2+</sup> ion that is unique to the C2-domain–DHPC complex is shown as a pale magenta sphere; whereas the other two Ca<sup>2+</sup> ions are shown as green spheres. In the bound DHPC structure, blue, red, orange, and beige colors represent nitrogen, oxygen, phosphorus, and carbon atoms, respectively. The zoomed view shows how the orientation and position of the PC headgroup bound by the C2-domain requires no major conformational change relative to those of unbound PC headgroups comprising the membrane interface. Membrane docking orientation and penetration depth by the C2-domain are based on previous data illustrated in panel (<bold>B</bold>) (<xref ref-type="bibr" rid="bib52">Nalefski and Falke, 1998</xref>; <xref ref-type="bibr" rid="bib3">Ball et al., 1999</xref>; <xref ref-type="bibr" rid="bib44">Malmberg et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">Malmberg and Falke, 2005</xref>). (<bold>B</bold>) cPLA<sub>2</sub>α C2-domain docking orientation and penetration depth at the membrane interface, as determined by electron paramagnetic resonance power saturation. [Reprinted (adapted) with permission <xref ref-type="bibr" rid="bib44">Malmberg et al., 2003</xref>, Biochemistry 42, 13227–13240. Copyright: American Chemical Society.]. The crystal structure of the lipid-free C2-domain (PDB: RLW) is represented by the cyan ribbon with two Ca<sup>2+</sup> ions shown as yellow spheres. The horizontal lines represent planar boundaries for the lipid headgroup and hydrocarbon regions of the bilayer. Protein spin labels oriented in their final optimized conformations are colored according to their measured depth parameters (Φ), with positive and negative depth parameters indicated by increasing red and blue color intensity, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig5-v3.tif"/></fig><p>In other recent studies, cPLA<sub>2</sub>α has been implicated as an inducer of membrane structural changes in cells (<xref ref-type="bibr" rid="bib30">Grimmer et al., 2005</xref>; <xref ref-type="bibr" rid="bib61">San Pietro et al., 2009</xref>; <xref ref-type="bibr" rid="bib11">Cai et al., 2012</xref>). This function occurs independently of catalytic activity, but is important for physiological processes such as the regulation of Fc-receptor-mediated phagocytosis (<xref ref-type="bibr" rid="bib85">Zizza et al., 2012</xref>). The membrane structural alterations that are mediated by cPLA<sub>2</sub>α have been linked to the C2–domain, which can generate membrane curvature and tubulation in vitro (<xref ref-type="bibr" rid="bib78">Ward et al., 2012</xref>). Penetration by the cPLA<sub>2</sub>α C2-domain into POPC or POPC/POPE/POPS membranes induces positive membrane curvature that is abrogated by Y96A mutation, F35A/L39A double mutation, or Ca<sup>2+</sup> chelation by EGTA (ethylene glycol-bis(β-aminoethyl ether) (<xref ref-type="bibr" rid="bib78">Ward et al., 2012</xref>). In this regard, it is interesting to note that the crystal structure of the C2-domain–DHPC complex contains three C2-domain molecules (protomers A, B, C) in the asymmetric unit, with the six protomers in two asymmetric units forming a ring-like structure (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, upper left panel). The DHPC molecules contribute to the molecular packing of neighboring molecules by locating inside the ring, resulting in a tube-like structure that is enclosed by the C2-domain ring (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, upper right panel). Thus, the crystal packing superstructure of the cPLA<sub>2</sub>α C2-domain complexed with DHPC supports the induction of positive membrane curvature and tubulation reported for this C2-domain (<xref ref-type="bibr" rid="bib78">Ward et al., 2012</xref>), an arrangement not supported well by the different crystal packing structure of lipid-free C2-domain (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, lower panel).</p><sec id="s3-1"><title>Comparison of phospholipid recognition by the PKCα C2-domain and other C2-domains</title><p>Structural analyses of four other C2-domains containing bound phosphoglycerides have been reported. In the C2-domains of PKCα and rabphilin-3A, phosphatidylinositol 4,5-bisphosphate binding occurs at a basic residue cluster without Ca<sup>2+</sup> involvement (<xref ref-type="bibr" rid="bib31">Guerrero-Valero et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Zizza et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">Verdaguer et al., 1999</xref>). By contrast, only two other C2–domain structures have to date been found to utilize bound Ca<sup>2+</sup> to mediate phosphoglyceride binding: PKCα C2–domain complexed with 1,2-dicaproyl-<italic>sn</italic>-phosphatidyl-L-serine (DCPS), a short-chain PS analog (<xref ref-type="bibr" rid="bib76">Verdaguer et al., 1999</xref>) and Syt1 C2B–domain complexed with phosphoserine (<xref ref-type="bibr" rid="bib32">Guillén et al., 2013</xref>). In the DCPS–PKCα C2–domain structure (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), one of three bound Ca<sup>2+</sup> ions is coordinated in a position similar to that of Ca1 in the cPLA<sub>2</sub> C2–domain (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), whereas the others are located at different positions far from CBL2 (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). In sharp contrast to DHPC recognition by cPLA<sub>2</sub>α, binding of the phosphoryl group of DCPS involves only Ca1. The seryl moiety of the head group docks mainly with CBL1 but in an orientation (<xref ref-type="fig" rid="fig6">Figure 6B</xref>) that is almost opposite to that of the bound phosphorylcholine in the cPLA<sub>2</sub>α C2–domain–DHPC complex (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The seryl carboxyl group hydrogen bonds with Asn189 on CBL1, whereas the carbonyl groups of the fatty acid chains interact with CBL2 and CBL3. In the structures of the Syt1 C2B-domain complexed with phosphoserine (<xref ref-type="bibr" rid="bib25">Ferrer-Orta et al., 2017</xref>) (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) and the lipid-free Syt1 C2A-domain (<xref ref-type="bibr" rid="bib63">Shao et al., 1998</xref>) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), three bound Ca<sup>2+</sup> ions are coordinated similarly to those in the cPLA2α C2-domain but only the Ca1 position is shared with the cPLA2α C2-domain (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). In the Syt1 C2B–domain (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), the seryl moiety docks deeply towards the Ca<sup>2+</sup> ion sites, whereas the phosphoryl group interacts with Lys366 in CBL3, but not with any Ca<sup>2+</sup> ions. Within the seryl moiety, the carboxyl group interacts with Ca1 and the main chain of Lys366, while the amine group forms a hydrogen bond with Asp309. This binding mode differs from PS recognition by PKCα, although the lack of fatty acyl chains might be the cause of the different interaction. Thus, it is clear that PC recognition by the cPLA<sub>2</sub>α C2-domain (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) is very different from PS recognition by the C2-domains of PKCα2 and Syt1 (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). Among eukaryotes, Tyr96 and Asn65 are absolutely conserved in cPLA<sub>2</sub>α, but not in PKCs or synaptotagmin1 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Structures of various C2-domains bound to lipids.</title><p>(<bold>A</bold>) cPLA<sub>2</sub>α C2-domain bound to DHPC determined in this study. (<bold>B</bold>) PKCα C2-domain bound to phosphatidylserine (PDB 1DSY). (<bold>C</bold>) Synaptotagmin-1 C2B-domain bound to phosphoserine (PDB 2YOA). For comparison, Ca4 (purple sphere) and Ca<sup>PC</sup> (pink sphere) in panel (<bold>A</bold>) are overlaid as pale white spheres in panels (<bold>B</bold>) and (<bold>C</bold>). Residues that are interacting directly with ligand are shown as stick models and labeled in red.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Ca<sup>2+</sup>binding site differences in the synaptotagmin-1 C2A domain versus the cPLA<sub>2</sub>α C2-domain complexed with DHPC.</title><p>cPLA<sub>2</sub>α C2-domain complexed with DHPC. cPLA<sub>2</sub>α C2-domain (green) is shown with bound Ca<sup>2+</sup> (green) and bound DHPC (yellow). Both Ca4 and Ca<sup>PC</sup> are directly involved in DHPC binding. Synaptotagin-1 C2A domain (beige) also binds three Ca<sup>2+</sup> atoms (plum) (PBD:1BYN). Only one Ca<sup>2+</sup> binding site (Ca1) overlaps with cPLA2 C2-domain. In contrast, all three Ca<sup>2+</sup> binding positions in synaptotagin-1 C2B domain (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) overlap with those in synaptotagin-1 C2A. Ca<sup>2+</sup> binding site identification corresponds with the numbering system of <xref ref-type="bibr" rid="bib59">Rizo and Südhof (1998)</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig6-figsupp1-v3.tif"/></fig></fig-group><p>Recent structural studies of another cPLA<sub>2</sub>, cPLA<sub>2</sub>δ, have provided molecular insights into the apo-form and the enzyme’s catalytic domain complexed with a covalently linked inhibitor (tri-unsaturated 18-carbon phosphonate), but not into phosphoglyceride binding by the enzyme’s two tandem C2-domains (<xref ref-type="bibr" rid="bib77">Wang et al., 2016</xref>). Although a general model is proposed for the membrane interaction of cPLA<sub>2</sub>δ, involving its tandem C2-domains, this model does not address the issue of phosphoglyceride selectivity.</p><p>Our findings point to the key role of cation–π interactions provided by Tyr96 for targeting lipids containing phosphorylcholine headgroups (e.g. PC and SM). Aromatic side-chains (e.g. Tyr and Trp) in mammalian PC transfer protein and in yeast Sec14 transfer protein play a key role in selectivity for PC (<xref ref-type="bibr" rid="bib60">Roderick et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Kang et al., 2010</xref>; <xref ref-type="bibr" rid="bib62">Schaaf et al., 2008</xref>), as well as in the SM selectivity reported for actinoporin toxins produced by sea anemones (<xref ref-type="bibr" rid="bib29">García-Ortega et al., 2011</xref>). Moreover, Tyr residues that are introduced in close proximity by mutation into peripheral proteins induce a specific interaction with PC in membranes (<xref ref-type="bibr" rid="bib14">Cheng et al., 2013</xref>). Examination of the X-ray structure of the cPLA<sub>2</sub>α catalytic domain (<xref ref-type="bibr" rid="bib21">Dessen et al., 1999</xref>) reveals a cluster of aromatic residues (Tyr, Trp, and Phe) in close proximity to the Arg200/Ser228/Asp549 catalytic site residues. Thus, it is tempting to predict that a ‘cation-π box’ is likely to contribute prominently to the structural underpinning of PAPC selectivity that enables the release of arachidonic acid.</p><p>Notably, sequence alignment of the C2-domains of cPLA<sub>2</sub>α, cPLA<sub>2</sub>δ, and three other isoforms shows that the residues (Tyr96 and Asn65), which are so crucial for phosphorylcholine lipid headgroup selectivity by cPLA<sub>2</sub>α C2-domain are not conserved in cPLA<sub>2</sub>δ and correspond to Ser97 and Asp66, respectively (<xref ref-type="fig" rid="fig7">Figure 7</xref>). These residues are unable to undergo cation-π interaction with the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group or favorable polar interaction with the phosphoryl group of the PC headgroup. cPLA<sub>2</sub>α is the only cPLA<sub>2</sub> isoform that contains a residue (e.g. Tyr96) capable of strong cation-π interaction with the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> group in PC. It is also noteworthy that Tyr96 is highly conserved among eukaryotic C2-domains of the cPLA<sub>2</sub>α isoform (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). These observations suggest that the structure of the C2-domain of cPLA<sub>2</sub>α contains design features that promote PC selectivity.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>C2-domain sequence alignment for five human cPLA<sub>2</sub> isoforms showing the uniqueness of the Tyr96 residue in the cPLA<sub>2</sub>α C2-domain.</title><p>β-strand sequences (arrows) as well as CBL2 and CBL3 sequences (bracketed) are shown above the alignment. Green highlights represent identical residues. Cyan highlights represent similar residues. The yellow highlights facilitate comparison of other isoform residues with N65 and Y96 (red) which are key for PC selectivity by the cPLA<sub>2</sub>α C2-domain. Underlined black residues in cPLA<sub>2</sub>α (R59, R61, and H62) participate in C1P binding (<xref ref-type="bibr" rid="bib69">Stahelin et al., 2007</xref>; <xref ref-type="bibr" rid="bib79">Ward et al., 2013</xref>). Sequence alignment was generated using Clustal Omega.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-44760-fig7-v3.tif"/></fig></sec><sec id="s3-2"><title>Conclusions</title><p>Our findings support a function for cPLA<sub>2</sub>α Tyr96 [via cation-π interaction with -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub>] as a key specificity determinant for the phosphorylcholine headgroup of PC, whereas Asn65 tethers with the lipid phosphate moiety and facilitates Ca<sup>PC</sup> complexation. Notably, Ca4 also functions to tether the PC phosphate moiety to the protein. Bridging by Ca<sup>PC</sup> to the PC <italic>sn-</italic>2 chain ester linkage further aids enzyme binding and ‘scooting’ on PC membranes. Further enhancement of C2-domain binding to the membrane, via interaction with Arg59, Arg61 and His 62, is expected when PC-enriched membranes also contain C1P. Taken together, the findings emphasize the unique design features associated with cPLA<sub>2</sub>α C2-domain structure and function, as well as the versatility of lipid recognition exhibited by different C2–domains. In cPLA<sub>2</sub>α, the C2-domain is structurally designed to target PC-rich membrane regions in order to increase the enzymatic efficiency of the catalytic domain, which prefers polyunsaturated PCs.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td>BL21 (DE) Star competent cells</td><td>ThermoFisher Scientific</td><td>SKU# C6010-03</td><td>Cells for protein <break/>expression</td></tr><tr><td>Transfected construct (<italic>E. coli</italic>)</td><td>pET SUMO</td><td>Snapgene</td><td><ext-link ext-link-type="uri" xlink:href="https://www.snapgene.com/resources/plasmid-files/?set=ta_and_gc_cloning_vectors&amp;plasmid=pET_SUMO_">https://www.snapgene.com/resources/plasmid-files/?set=ta_and_gc_cloning_vectors&amp;plasmid=pET_SUMO</ext-link> <break/><ext-link ext-link-type="uri" xlink:href="https://www.snapgene.com/resources/plasmid-files/?set=ta_and_gc_cloning_vectors&amp;plasmid=pET_SUMO_">_</ext-link>(linearized)</td><td>Protein expression vector</td></tr><tr><td>Commercial assay or kit</td><td>JCSG Core Suites</td><td>Qiagen</td><td><ext-link ext-link-type="uri" xlink:href="https://www.qiagen.com/us/shop/sample-technologies/protein/crystallization/the-jcsg-core-suites/#orderinginformation">https://www.qiagen.com/us/shop/sample-technologies/protein/crystallization/the-jcsg-core-suites/#orderinginformation</ext-link></td><td>Protein crystallization; crystallization <break/>screening kit</td></tr><tr><td>Chemical compound, drug</td><td>1,2-dihexanoyl <break/>-sn-glycero-3- <break/>phosphocholine</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/850305/">https://avantilipids.com/product/850305/</ext-link></td><td>DHPC</td></tr><tr><td>Chemical compound, drug</td><td>1-palmitoyl-2- <break/>oleoyl-glycero-3- <break/>phosphocholine</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/850457/">https://avantilipids.com/product/850457/</ext-link></td><td>POPC</td></tr><tr><td>Chemical compound, drug</td><td>1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/840034/">https://avantilipids.com/product/840034/</ext-link></td><td>POPS</td></tr><tr><td>Chemical compound, drug</td><td>1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/850757">https://avantilipids.com/product/850757</ext-link></td><td>POPE</td></tr><tr><td>Chemical compound, drug</td><td>1-palmitoyl-2- <break/>oleoyl-sn-glycero-3-phosphate</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/840857">https://avantilipids.com/product/840857</ext-link></td><td>POPA</td></tr><tr><td>Chemical compound, drug</td><td>1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/840457">https://avantilipids.com/product/840457</ext-link></td><td>POPG</td></tr><tr><td>Chemical compound, drug</td><td>N-oleoyl-D-erythro-sphingosylphosphorylcholine</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/860587">https://avantilipids.com/product/860587</ext-link></td><td>18:1 SM</td></tr><tr><td>Chemical compound, drug</td><td>1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2–1,3-benzoxadiazol-4-yl)</td><td>Avanti Polar Lipids</td><td><ext-link ext-link-type="uri" xlink:href="https://avantilipids.com/product/810145">https://avantilipids.com/product/810145</ext-link></td><td>NBD-PE</td></tr><tr><td>Software, algorithm</td><td>GeneCards</td><td><ext-link ext-link-type="uri" xlink:href="http://genecards.org">http://genecards.org</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002773">SCR_002773</ext-link></td><td>Orthologs; retrieval of protein sequences for human, mouse, and chicken proteins</td></tr><tr><td>Software, algorithm</td><td>UniProtKB</td><td><ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/help/uniprotkb">http://www.uniprot.org/help/uniprotkb</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004426">SCR_004426</ext-link></td><td>C2-domain sequences for various proteins and organisms</td></tr><tr><td>Software, algorithm</td><td>NCBI Protein</td><td><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein">http://www.ncbi.nlm.nih.gov/protein</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003257">SCR_003257</ext-link></td><td>Protein sequences for human, mouse, and chicken proteins</td></tr><tr><td>Software, algorithm</td><td>Clustal Omega</td><td><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalo/">http://www.ebi.ac.uk/Tools/msa/clustalo/</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001591">SCR_001591</ext-link></td><td>Software package for multiple sequence alignment</td></tr><tr><td>Software, algorithm</td><td>Clustal W2</td><td><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalw2/">http://www.ebi.ac.uk/Tools/</ext-link> <break/><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalw2/">msa/clustalw2/</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002909">SCR_002909</ext-link></td><td>Multiple sequence alignment program for DNA or proteins.</td></tr><tr><td>Software, algorithm</td><td valign="bottom">UCSF Chimera</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://plato.cgl.ucsf.edu/chimera/">http://plato.cgl.ucsf.edu/chimera/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004097">SCR_004097</ext-link></td><td valign="bottom">Program for <break/>interactive visualization and analysis of molecular structures</td></tr><tr><td>Software, algorithm</td><td valign="bottom">Protein Data Bank (PDB)</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.wwpdb.org/">http://www.wwpdb.org/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006555">SCR_006555</ext-link></td><td valign="bottom">Macromolecular structure archive that oversees and reviews deposition and processing data</td></tr><tr><td>Software, algorithm</td><td valign="bottom">Coot</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/">http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014222">SCR_014222</ext-link></td><td valign="bottom">Software for macromolecular model building, completion and <break/>validation, and protein modeling using <break/>X-ray data</td></tr><tr><td>Software, algorithm</td><td valign="bottom">PHENIX</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.phenix-online.org/">https://www.phenix-online.org/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014224">SCR_014224</ext-link></td><td valign="bottom">Python-based <break/>software suite for determination of X-ray <break/>crystallographic molecular structures</td></tr><tr><td>Software, algorithm</td><td valign="bottom">PyMol</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/">http://www.pymol.org/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000305">SCR_000305</ext-link></td><td valign="bottom">Data processing, <break/>3D visualization and rendering <break/>software</td></tr><tr><td>Software, algorithm</td><td valign="bottom">PDBeFold</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://pdbe.org/fold/">http://pdbe.org/fold/</ext-link></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004312">SCR_004312</ext-link></td><td valign="bottom">Co-alignment of <break/>compared structures</td></tr><tr><td>Peptide, recombinant protein</td><td>Cytosolic phospholipase A2</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P47712">https://www.uniprot.org/uniprot/P47712</ext-link></td><td valign="bottom"/><td valign="bottom">Human cPLA2 sequence</td></tr><tr><td>Peptide, recombinant protein</td><td>Cytosolic <break/>phospholipase A2</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P47713">https://www.uniprot.org/uniprot/P47713</ext-link></td><td valign="bottom"/><td valign="bottom">Mouse cPLA2 sequence</td></tr><tr><td>Peptide, recombinant protein</td><td>Cytosolic phospholipase A2</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P49147">https://www.uniprot.org/uniprot/P49147</ext-link></td><td valign="bottom"/><td valign="bottom">Chicken cPLA2 sequence</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Strategy employed to achieve a soluble cPLA2α C2-domain</title><p>The C2-domain sequence used to achieve solubility during expression and to avoid the need for protein refolding was developed by consideration of the original lipid-free, Ca<sup>2+</sup>-bound crystal structure (<xref ref-type="bibr" rid="bib55">Perisic et al., 1998</xref>) that used a truncated C2-domain (residues 17–141) from human cPLA2α. However, we did not introduce the C-terminal C139A and C141S substitutions that were implemented to eliminate possible refolding complications induced by Cys residues, because our goal was to recover soluble protein after expression in <italic>Escherichia coli</italic>. In our constructs, the <italic>Bam</italic>HI and <italic>Sal</italic>I restriction sites were used for open reading frame (ORF) ligation into a modified pET-28-SUMO vector (kanamycin-resistance). Prior to insertion, the open reading frames were mutated to remove a single <italic>Bam</italic>HI restriction site within the C2-domain ORF without changing the protein sequence. The complete protein sequences for cPLA2α from human, mouse, and chicken are provided in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. The constructs, which were verified by DNA sequencing, enabled the expression of proteins containing Ulp1-cleavable, N-terminal 6xHis-SUMO tags. Testing for their solubility and SUMO-tag cleavability revealed the following:</p><sec id="s4-1-1"><title>Human</title><list list-type="bullet"><list-item><p>C2-domain<sup>1–140</sup> or C2-domain<sup>15–140</sup> expression resulted in mostly insoluble protein located in inclusion bodies.</p></list-item><list-item><p>C2-domain<sup>17–140</sup> expression resulted in soluble protein but with a SUMO tag that was inaccessible to cleavage.</p></list-item><list-item><p>Expression of C2-domain<sup>17–140</sup> with an inserted Gly or Met residue at the N-terminus (C2-domain <sup>Gly/Met-17–140</sup>) resulted in good expression of soluble protein and cleavage of the SUMO tag.</p></list-item></list></sec><sec id="s4-1-2"><title>Chicken</title><list list-type="bullet"><list-item><p>Expression of C2-domain<sup>16–140</sup> resulted in good expression of soluble protein and cleavage of the SUMO tag.</p></list-item></list></sec></sec><sec id="s4-2"><title>Protein expression and purification</title><p>Protein expression was performed at 20°C in Luria-Bertani medium containing 0.1 mM isopropyl-β-D-thiogalactopyranoside. Cells expressing the C2-domain were harvested, suspended in 20 mM Tris-HCl buffer (pH 8.0) containing 500 mM NaCl and disrupted by French press. After ultracentrifugation, the supernatant was applied onto a Ni-NTA resin (Qiagen) and treated with Ulp1 to remove the N-terminal His6-SUMO tag. Eluted proteins were further purified by anion exchange (HiTrap Q HP, GE Healthcare) and gel filtration (Superdex 75 pg, GE Healthcare) chromatography. Purified protein was concentrated up to 20 mg/mL in 20 mM MES-NaOH buffer (pH 6.0) containing 100 mM NaCl and 2.5 mM CaCl<sub>2</sub> and stored at −80°C until use.</p></sec><sec id="s4-3"><title>Crystallization and data collection</title><p>All lipids used in this study were obtained from Avanti Polar Lipids and dissolved in ethanol. Crystallization conditions were initially screened using a Mosquito crystallization robot (TTP Labtech) with commercial crystallization solution kits, JCSG Core Suite I-IV and PACT Suite (QIAGEN). Despite extensive crystallization trials with human C2-domain<sup>Gly-17–140</sup>, the only resulting protein crystals contained two bound Ca<sup>2+</sup> but no bound lipid. Successful crystallization of C2-domain containing bound DHPC and three bound Ca<sup>2+</sup>ions was obtained with the chicken C2-domain<sup>16–140</sup>. The best crystal complexes were obtained from solutions containing 1 mM protein, 5 mM DHPC and reservoir solution containing 100 mM HEPES-NaOH buffer (pH 7.0), 1.4 M MgCl<sub>2</sub> and 0.6 M NaCl at 20°C. Crystal complexes were transferred into a cryoprotective solution containing saturated NaCl and flash-cooled at 100 K. X-ray diffraction data were collected at 100 K on 24-ID-C beamline at the Advanced Photon Source. Data were processed and scaled using HKL-2000 (<xref ref-type="bibr" rid="bib54">Otwinowski and Minor, 1997</xref>). The crystal data and refinement statistics are summarized in <xref ref-type="table" rid="table5">Table 5</xref> and are deposited in the Protein Data Bank (accession code 6IEJ).</p><table-wrap id="table5" position="float"><label>Table 5.</label><caption><title>X-ray data collection statistics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">Native</th></tr></thead><tbody><tr><td valign="top"><bold>Data collection</bold></td><td valign="top"/></tr><tr><td valign="top"><bold>Space group</bold></td><td valign="top"><italic>C</italic>222</td></tr><tr><td valign="top"><bold>Cell dimensions</bold></td><td valign="top"/></tr><tr><td valign="top"><italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Å)</td><td valign="top">108.3, 187.4, 68.8</td></tr><tr><td valign="top">Wavelength (Å)</td><td valign="top">1.00000</td></tr><tr><td valign="top">Resolution (Å) *</td><td valign="top">50–2.20 (2.24–2.20)</td></tr><tr><td valign="top"><italic>R</italic><sub>sym</sub>*</td><td valign="top">5.9 (36.3)</td></tr><tr><td valign="top"><italic>I</italic>/σ<italic>I</italic>*</td><td valign="top">30.9 (1.9)</td></tr><tr><td valign="top">Completeness (%)*</td><td valign="top">99.5 (97.7)</td></tr><tr><td valign="top">Redundancy*</td><td valign="top">7.7 (6.6)</td></tr><tr><td valign="top"><bold>Refinement</bold></td><td valign="top"/></tr><tr><td valign="top">Resolution (Å)</td><td valign="top">47–2.2</td></tr><tr><td valign="top">No. reflections</td><td valign="top">35,185</td></tr><tr><td valign="top"><italic>R</italic><sub>work</sub>/<italic>R</italic><sub>free</sub> (%)</td><td valign="top">22.4/24.9</td></tr><tr><td valign="top">No. atoms</td><td valign="top"/></tr><tr><td valign="top">Protein</td><td valign="top">2998</td></tr><tr><td valign="top">Water</td><td valign="top">82</td></tr><tr><td valign="top">Ion</td><td valign="top">11</td></tr><tr><td valign="top">Ligand</td><td valign="top">75</td></tr><tr><td valign="top"><bold>B-factor (Å<sup>2</sup>)</bold></td><td valign="top"/></tr><tr><td valign="top"><bold>Protein</bold></td><td valign="top">59.9</td></tr><tr><td valign="top">Water</td><td valign="top">56.6</td></tr><tr><td valign="top">Ion</td><td valign="top">54.2</td></tr><tr><td valign="top">Ligand</td><td valign="top">81.3</td></tr><tr><td valign="top">R.m.s. deviations</td><td valign="top"/></tr><tr><td valign="top">Bond lengths (Å)</td><td valign="top">0.008</td></tr><tr><td valign="top">Bond angles (°)</td><td valign="top">1.117</td></tr></tbody></table><table-wrap-foot><fn><p>One crystal was used for each data set.</p><p><sup>*</sup>Highest resolution shell is shown in parenthesis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4-4"><title>Structure determination and refinement</title><p>The structure of the crystal complex was determined by a molecular replacement method using the lipid-free structure of the human cPLA<sub>2</sub>α C2-domain (PDB: 1RLW) as a starting model. The built model was refined using alternating cycles of the Coot (<xref ref-type="bibr" rid="bib23">Emsley and Cowtan, 2004</xref>) and PHENIX programs (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>). The model was refined to 2.2 Å resolution. Refinement statistics are summarized in <xref ref-type="table" rid="table5">Table 5</xref>.</p><p>Electron density mapping of the lipid ligand involved consideration of the chemical structures of both DHPC and MES because MES was included in our crystallization buffer. The omit map (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) clearly traced density corresponding to the -N<sup>+</sup>(CH<sub>3</sub>)<sub>3</sub> and phosphate groups of the DHPC head group, as well as extra density corresponding to the ester groups of fatty acid chains rather than to the morpholino and sulfate groups of MES. When we tried to place the MES molecule at this position, the extra strong density corresponding to fatty acid chains stood out. Thus, we identified our structure as DHPC bound to C2–domain.</p></sec><sec id="s4-5"><title>Structure and sequence comparison</title><p>Multiple sequence alignment was performed by CLUSTALW (<xref ref-type="bibr" rid="bib23">Emsley and Cowtan, 2004</xref>). Pairwise structural comparisons were performed using C<sub>α</sub>-atom positions by the PDBeFold (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) in conjunction with SSM (<xref ref-type="bibr" rid="bib37">Krissinel and Henrick, 2004</xref>) and structure figures were prepared using the PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/">http://www.pymol.org/</ext-link>) and UCSF Chimera 1.11.2 (<ext-link ext-link-type="uri" xlink:href="http://www.cgl.ucsf.edu/chimera/">http://www.cgl.ucsf.edu/chimera/</ext-link>).</p></sec><sec id="s4-6"><title>Point-mutant analyses of C2-domain translocation to PC model membranes</title><p>Partitioning of C2-domain and various point mutants to PC model membranes was monitored by FRET and SPR. FRET measurements were performed using Trp/Tyr emission of C2-domain as energy donor and dansyl-PE-POPC-DHPC (5:45:50) bicelle-dilution vesicles as energy acceptors. Bicelle-dilution vesicles were formed by mixing the POPC, dansyl-PE and DHPC in chloroform, drying under a stream of nitrogen and placing under vacuum for ~2 hr, before resuspending in buffer (20 mM Tris, pH 7.5, 150 mM NaCl and 50 µM CaCl<sub>2</sub>). Unilamellar POPC vesicle preparation by POPC/DHPC bicelle mix dilution is detailed in <xref ref-type="bibr" rid="bib27">Gao et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Gao et al., 2021</xref>. Binding reactions included C2-domain (0.5 µM) and various amounts of bicelle-dilution vesicles (PC concentration 0.44 to 20 µM) in 2.5 ml of buffer. In binding reactions assessing calcium dependence (2.5 ml total volume), the protein and bicelle dilution-vesicle concentrations (0.5 µM and 4 µM, respectively) were held constant while the Ca<sup>2+</sup> was varied. FRET measurements were performed at 25°C in a temperature-controled (±0.1°C) cuvette (NesLab RTE-111, ThermoFisher) using a SPEX FluoroLog-3 spectrofluorimeter (Horiba Scientific). Excitation and emission wavelengths were 284 nm and 520 nm, with band-pass settings of 5 and 10 nm, respectively. Inner filter effects were avoided by using low protein concentration (optical density @ 295 nm &lt;0.1). Relative FRET was calculated as (I<sub>obs</sub> – I<sub>min</sub>) / (I<sub>max</sub> – I<sub>min</sub>), where I<sub>min</sub> is the dansyl emission in the absence of Ca<sup>2+</sup> and I<sub>max</sub> is the maximal energy transfer obtained from the binding curve. FRET fluorescence data were plotted as the relative fluorescence signal versus PC concentration and fitted to the equation described by <xref ref-type="bibr" rid="bib57">Rao et al. (2005)</xref>.</p><p>SPR measurements were performed using a Biacore T200 system (GE Healthcare Bio-Sciences Corp) at 25°C under previously described conditions (<xref ref-type="bibr" rid="bib69">Stahelin et al., 2007</xref>; <xref ref-type="bibr" rid="bib78">Ward et al., 2012</xref>; <xref ref-type="bibr" rid="bib79">Ward et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Zhai et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Ochoa-Lizarralde et al., 2018</xref>). An uncoated flow channel was used as a control surface. POPC vesicles (1 mM), prepared by sonication and centrifugation, were captured to a final surface density of 4000–6000 response units on a L1 Sensor Chip to establish the baseline. Each lipid layer was stabilized by injecting 10 μl of 50 mM NaOH three times. Then 100 μl of protein in 10 mM HEPES (pH 7.4), 0.16 M KCl and 50 μM CaCl<sub>2</sub> was injected at 5 μl/min flow rate and protein adsorption was monitored. After 20 min, a switch to buffer lacking protein occurred (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>) but the strong adsorption of the C2-domain required washing with 10 μl of 50 mM NaOH to regenerate the lipid surface. Complete cleaning of the sensor chip could be accomplished by washing with 20 mM CHAPS detergent. The normalized saturation response R<sub>eq</sub> was plotted versus protein concentration (C), and <italic>K</italic><sub>d</sub> values were determined by nonlinear least-squares fitting using the equation: R<sub>eq</sub> = R<sub>max</sub>/(1 + K<sub>d</sub><italic>/</italic>C). Each data set was repeated three times to calculate a standard deviation value.</p></sec><sec id="s4-7"><title>cPLA<sub>2</sub> activity measurements</title><p>A mixed micelle was utilized to measure PAPC hydrolysis by cPLA<sub>2</sub> as previously reported (<xref ref-type="bibr" rid="bib81">Wijesinghe et al., 2009</xref>). Briefly 4x assay buffer (2 ml) was made using 320 mM HEPES, 600 mM NaCl, 19.42 μM CaCl<sub>2</sub> (10 μM free Ca<sup>2+</sup>), 10 μM EGTA, 4 mM DTT, and 2.39% H<sub>2</sub>O. For K<sub>0.5</sub> analysis, micelles were created by drying down ten separate concentrations of PAPC by nitrogen and then reconstituting in 8 mM Triton-X100. Micelle concentrations are as follows: 50 μM PC (2.4% mol PC), 100 μM PC (4.7% mol PC), 150 μM PC (6.9% mol PC), 200 μM PC (9.1% mol PC), 300 μM PC (13% mol PC), 400 μM PC (16.6% mol PC), 500 μM PC (20% mol PC), 800 μM PC (28.6% mol PC), 1200 μM PC (37.5% mol PC), and 1600 μM PC (44.4% mol PC). For K<sub>s</sub>A analysis, all six concentrations of micelles were created by first making a 1600 μM PC micelle by drying down PAPC and reconstituting in Triton-X100. The 1200 μM, 800 μM, 500 μM, 300 μM, and 100 μM PC micelles were made via serial dilution of the 1600 μM micelle with LCMS-grade H<sub>2</sub>O.</p><p>To prepare for enzyme for assays, cPLA<sub>2</sub>α (250 ng) was mixed with 30% glycerol and 80 mM HEPES. Assay buffer (25 μL) was then combined with micelles (25 μL), followed by protein mix (50 μL) to produce a final reaction volume of 100 μL. A total of five reactions were prepared for each of the ten concentrations. Immediately following enzyme addition to the micelle – assay buffer mixture, a timer was started and mixtures were placed into a 37°C bead bath. At 15, 30, 45, and 60 min, a 100 μL aliquot was pipetted from each concentration into 500 μL of MeOH containing 10 ng of arachidonic acid-d<sub>8</sub> (AAd8) to quench the reaction. Samples then were assessed for PAPC hydrolysis via UPLC-LC/MS. Kinetic and statistical analyses were performed using GraphPad Prism 6 (GraphPad Software Inc).</p><p>AA and AAd8 were purchased from Cayman Chemicals and analyzed using an adapted method from our previous report (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951269/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951269/</ext-link>). AA and AAd8 were separated with an Acentis Express C18 HPLC Column 10 cm x 2.1 mm, 2.7 μm via UPLC using a Shimadzu 2-D UPLC Nexera System in conjunction with a QTRAP 5500 Mass Spectrometer (AbSciex). Mass spectrometry parameters were: Polarity, Negative; Ion Source, Electrospray; Q1 Resolution, Unit; Q3 Resolution, Unit; Curtain Gas, 30; Collision Gas, Medium; IonSpray Voltage, −4500; Temperature, 500; Ion Source Gas 1, 40; Ion Source Gas 2, 60; Entrance Potential, −13. MRM transitions with corresponding declustering potentials (DP), collision energies (CE), and collision cell exit potentials (CXP) were: AA Q1 Mass (da), 303.2; Q3 Mass (da), 259.2; DP, −150 volts; CE, −17 volts; CXP, −14 volts. AAd8 Q1 Mass (da), 311.2; Q3 Mass (da), 267.3; DP, −150 volts; CE, −18 volts; and CXP, −16 volts.</p><p>UPLC conditions were: Pumping Mode, Binary Flow; Total Flow, 0.7000 mL/min; Injection Volume, 10 μL; Column Oven, 60 °C. The solvents used for reverse phase UPLC separation across a 6 min run were: Solvent A – 60:40 acetonitrile/water with 0.1% formic acid and 10 mM ammonium formate; and Solvent B – 10:90 acetonitrile/isopropanol with 0.1% formic acid and 10 mM ammonium formate. Solvent conditions for UPLC separation were: 10% Solvent B from 0 to 1 min, linear increase from 10–100% Solvent B from 1 to 4 min; constant 100% Solvent B from 4 to 5 min; at 5 min, a drop from 100–10% solvent B; from 5 to 6 min, 10% constant solvent B; and at 6.1 min, Controller Stop. Because membranes are allosteric activators of cPLA<sub>2</sub>α <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib48">Mouchlis et al., 2015</xref>), both kinetic curves were fit using a non-linear regression allosteric sigmoidal best-fit approach. Statistical analyses were a single ANOVA with a Tukey HSD post-hoc test with p&lt;0.01 considered significant.</p></sec><sec id="s4-8"><title>Accession number</title><p>The atomic coordinates and structure factors for chicken cPLA<sub>2</sub>α C2-domain bound to DHPC are deposited in Protein Data Bank under accession code 6IEJ.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This work was also supported by the Program for Promoting the Enhancement of Research Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (YH); research grants from the National Institutes of Health via HL125353 (CEC, REB, and DJP), HD087198 (CEC), and RR031535 (CEC); the Veteran’s Administration [VA Merit Review, I BX001792 (CEC)]; a Research Career Scientist Award 13F-RCS-002 (CEC); a Memorial Sloan-Kettering Cancer Center Core Grant P30 CA008748 (DJP); the Maloris Foundation (DJP); and the Hormel Foundation (REB). The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Investigation, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Validation</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Funding acquisition, Validation, Investigation, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="msword" mimetype="application" xlink:href="elife-44760-transrepform-v3.doc"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Diffraction data have been deposited in PDB under the accession code 6IEJ.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Yoshinori</surname><given-names>Hirano</given-names></name><name><surname>Yong-Guang</surname><given-names>Gao</given-names></name><name><surname>Daniel</surname><given-names>J Stephenson</given-names></name><name><surname>Ngoc</surname><given-names>T Vu</given-names></name><name><surname>Lucy</surname><given-names>Malinina</given-names></name><name><surname>Charles</surname><given-names>E Chalfant</given-names></name><name><surname>Dinshaw</surname><given-names>J Patel</given-names></name><name><surname>Rhoderick</surname><given-names>E Brown</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Structural basis of phosphatidylcholine recognition by the C2-domain of cytosolic phospholipase A2α</data-title><source>Protein Data Bank</source><pub-id assigning-authority="RCSB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6IEJ">6IEJ</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>Hung</surname> <given-names>LW</given-names></name><name><surname>Ioerger</surname> <given-names>TR</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Sacchettini</surname> <given-names>JC</given-names></name><name><surname>Sauter</surname> <given-names>NK</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>PHENIX: building new software for automated crystallographic structure determination</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>58</volume><fpage>1948</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1107/S0907444902016657</pub-id><pub-id pub-id-type="pmid">12393927</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alakoskela</surname> <given-names>JM</given-names></name><name><surname>Söderlund</surname> <given-names>T</given-names></name><name><surname>Holopainen</surname> <given-names>JM</given-names></name><name><surname>Kinnunen</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Dipole potential and head-group spacing are determinants for the membrane partitioning of pregnanolone</article-title><source>Molecular Pharmacology</source><volume>66</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1124/mol.104.000075</pub-id><pub-id pub-id-type="pmid">15213308</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname> <given-names>A</given-names></name><name><surname>Nielsen</surname> <given-names>R</given-names></name><name><surname>Gelb</surname> <given-names>MH</given-names></name><name><surname>Robinson</surname> <given-names>BH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Interfacial membrane docking of cytosolic phospholipase A2 C2 domain using electrostatic potential-modulated spin relaxation magnetic resonance</article-title><source>PNAS</source><volume>96</volume><fpage>6637</fpage><lpage>6642</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.12.6637</pub-id><pub-id pub-id-type="pmid">10359764</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayburt</surname> <given-names>T</given-names></name><name><surname>Gelb</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Interfacial catalysis by human 85 kDa cytosolic phospholipase A2 on anionic vesicles in the scooting mode</article-title><source>Biochemistry</source><volume>36</volume><fpage>3216</fpage><lpage>3231</lpage><pub-id pub-id-type="doi">10.1021/bi961659d</pub-id><pub-id pub-id-type="pmid">9115999</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittova</surname> <given-names>L</given-names></name><name><surname>Sumandea</surname> <given-names>M</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A structure-function study of the C2 domain of cytosolic phospholipase A2. identification of essential calcium ligands and hydrophobic membrane binding residues</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>9665</fpage><lpage>9672</lpage><pub-id pub-id-type="pmid">10092653</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonventre</surname> <given-names>JV</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Taheri</surname> <given-names>MR</given-names></name><name><surname>O'Leary</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>E</given-names></name><name><surname>Moskowitz</surname> <given-names>MA</given-names></name><name><surname>Sapirstein</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2</article-title><source>Nature</source><volume>390</volume><fpage>622</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/37635</pub-id><pub-id pub-id-type="pmid">9403693</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockman</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Dipole potential of lipid membranes</article-title><source>Chemistry and Physics of Lipids</source><volume>73</volume><fpage>57</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/0009-3084(94)90174-0</pub-id><pub-id pub-id-type="pmid">8001185</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockman</surname> <given-names>HL</given-names></name><name><surname>Momsen</surname> <given-names>MM</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name><name><surname>He</surname> <given-names>L</given-names></name><name><surname>Chun</surname> <given-names>J</given-names></name><name><surname>Byun</surname> <given-names>HS</given-names></name><name><surname>Bittman</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior</article-title><source>Biophysical Journal</source><volume>87</volume><fpage>1722</fpage><lpage>1731</lpage><pub-id pub-id-type="doi">10.1529/biophysj.104.044529</pub-id><pub-id pub-id-type="pmid">15345551</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>RE</given-names></name><name><surname>Brockman</surname> <given-names>HL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Using monomolecular films to characterize lipid lateral interactions</article-title><source>Methods in Molecular Biology</source><volume>398</volume><fpage>41</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-513-8_5</pub-id><pub-id pub-id-type="pmid">18214373</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname> <given-names>JE</given-names></name><name><surname>Hsu</surname> <given-names>YH</given-names></name><name><surname>Deems</surname> <given-names>RA</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Woods</surname> <given-names>VL</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>31227</fpage><lpage>31236</lpage><pub-id pub-id-type="doi">10.1074/jbc.M804492200</pub-id><pub-id pub-id-type="pmid">18753135</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>B</given-names></name><name><surname>Caplan</surname> <given-names>S</given-names></name><name><surname>Naslavsky</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>cPLA2α and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes</article-title><source>Molecular Biology of the Cell</source><volume>23</volume><fpage>1874</fpage><lpage>1888</lpage><pub-id pub-id-type="doi">10.1091/mbc.e11-10-0881</pub-id><pub-id pub-id-type="pmid">22456504</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Burke</surname> <given-names>JE</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Using hydrogen/deuterium exchange mass spectrometry to define the specific interactions of the phospholipase A2 superfamily with lipid substrates, inhibitors, and membranes</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>1806</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1074/jbc.R112.421909</pub-id><pub-id pub-id-type="pmid">23209293</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname> <given-names>J</given-names></name><name><surname>Gijón</surname> <given-names>MA</given-names></name><name><surname>Vigo</surname> <given-names>AG</given-names></name><name><surname>Crespo</surname> <given-names>MS</given-names></name><name><surname>Balsinde</surname> <given-names>J</given-names></name><name><surname>Balboa</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Phosphatidylinositol 4,5-bisphosphate anchors cytosolic group IVA phospholipase A2 to perinuclear membranes and decreases its calcium requirement for translocation in live cells</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-06-0545</pub-id><pub-id pub-id-type="pmid">16221889</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Goldstein</surname> <given-names>R</given-names></name><name><surname>Gershenson</surname> <given-names>A</given-names></name><name><surname>Stec</surname> <given-names>B</given-names></name><name><surname>Roberts</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The cation-π box is a specific phosphatidylcholine membrane targeting motif</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>14863</fpage><lpage>14873</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.466532</pub-id><pub-id pub-id-type="pmid">23576432</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>JD</given-names></name><name><surname>Lin</surname> <given-names>LL</given-names></name><name><surname>Kriz</surname> <given-names>RW</given-names></name><name><surname>Ramesha</surname> <given-names>CS</given-names></name><name><surname>Sultzman</surname> <given-names>LA</given-names></name><name><surname>Lin</surname> <given-names>AY</given-names></name><name><surname>Milona</surname> <given-names>N</given-names></name><name><surname>Knopf</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>A novel arachidonic acid-selective cytosolic PLA2 contains a <sup>ca(2+</sup>)-dependent translocation domain with homology to PKC and GAP</article-title><source>Cell</source><volume>65</volume><fpage>1043</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90556-E</pub-id><pub-id pub-id-type="pmid">1904318</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbalan-Garcia</surname> <given-names>S</given-names></name><name><surname>Gómez-Fernández</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Signaling through C2 domains: more than one lipid target</article-title><source>Biochimica Et Biophysica Acta (BBA) - Biomembranes</source><volume>1838</volume><fpage>1536</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2014.01.008</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Roles of catalytic domain residues in interfacial binding and activation of group IV cytosolic phospholipase A2</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>23838</fpage><lpage>23846</lpage><pub-id pub-id-type="doi">10.1074/jbc.M202322200</pub-id><pub-id pub-id-type="pmid">11956215</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davletov</surname> <given-names>B</given-names></name><name><surname>Perisic</surname> <given-names>O</given-names></name><name><surname>Williams</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>19093</fpage><lpage>19096</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.30.19093</pub-id><pub-id pub-id-type="pmid">9668093</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>Y</given-names></name><name><surname>Rivera-Molina</surname> <given-names>FE</given-names></name><name><surname>Toomre</surname> <given-names>DK</given-names></name><name><surname>Burd</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sphingomyelin is sorted at the <italic>trans</italic> golgi network into a distinct class of secretory vesicle</article-title><source>PNAS</source><volume>113</volume><fpage>6677</fpage><lpage>6682</lpage><pub-id pub-id-type="doi">10.1073/pnas.1602875113</pub-id><pub-id pub-id-type="pmid">27247384</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname> <given-names>EA</given-names></name><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Hsu</surname> <given-names>YH</given-names></name><name><surname>Magrioti</surname> <given-names>V</given-names></name><name><surname>Kokotos</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention</article-title><source>Chemical Reviews</source><volume>111</volume><fpage>6130</fpage><lpage>6185</lpage><pub-id pub-id-type="doi">10.1021/cr200085w</pub-id><pub-id pub-id-type="pmid">21910409</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessen</surname> <given-names>A</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>H</given-names></name><name><surname>Stahl</surname> <given-names>M</given-names></name><name><surname>Clark</surname> <given-names>JD</given-names></name><name><surname>Seehra</surname> <given-names>J</given-names></name><name><surname>Somers</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism</article-title><source>Cell</source><volume>97</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80744-8</pub-id><pub-id pub-id-type="pmid">10319815</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The cation-π interaction</article-title><source>Accounts of Chemical Research</source><volume>46</volume><fpage>885</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1021/ar300265y</pub-id><pub-id pub-id-type="pmid">23214924</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Coot: model-building tools for molecular graphics</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1107/S0907444904019158</pub-id><pub-id pub-id-type="pmid">15572765</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>JH</given-names></name><name><surname>Spencer</surname> <given-names>DM</given-names></name><name><surname>Zweifach</surname> <given-names>A</given-names></name><name><surname>Leslie</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>30150</fpage><lpage>30160</lpage><pub-id pub-id-type="doi">10.1074/jbc.M100943200</pub-id><pub-id pub-id-type="pmid">11375391</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer-Orta</surname> <given-names>C</given-names></name><name><surname>Pérez-Sánchez</surname> <given-names>MD</given-names></name><name><surname>Coronado-Parra</surname> <given-names>T</given-names></name><name><surname>Silva</surname> <given-names>C</given-names></name><name><surname>López-Martínez</surname> <given-names>D</given-names></name><name><surname>Baltanás-Copado</surname> <given-names>J</given-names></name><name><surname>Gómez-Fernández</surname> <given-names>JC</given-names></name><name><surname>Corbalán-García</surname> <given-names>S</given-names></name><name><surname>Verdaguer</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural characterization of the Rabphilin-3A-SNAP25 interaction</article-title><source>PNAS</source><volume>114</volume><fpage>E5343</fpage><lpage>E5351</lpage><pub-id pub-id-type="doi">10.1073/pnas.1702542114</pub-id><pub-id pub-id-type="pmid">28634303</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallivan</surname> <given-names>JP</given-names></name><name><surname>Dougherty</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cation-pi interactions in structural biology</article-title><source>PNAS</source><volume>96</volume><fpage>9459</fpage><lpage>9464</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9459</pub-id><pub-id pub-id-type="pmid">10449714</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>YG</given-names></name><name><surname>My Le</surname> <given-names>LT</given-names></name><name><surname>Zhai</surname> <given-names>X</given-names></name><name><surname>Boldyrev</surname> <given-names>IA</given-names></name><name><surname>Mishra</surname> <given-names>SK</given-names></name><name><surname>Tischer</surname> <given-names>A</given-names></name><name><surname>Murayama</surname> <given-names>T</given-names></name><name><surname>Nishida</surname> <given-names>A</given-names></name><name><surname>Molotkovsky</surname> <given-names>JG</given-names></name><name><surname>Alam</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Measuring lipid transfer protein activity using Bicelle-Dilution model membranes</article-title><source>Analytical Chemistry</source><volume>92</volume><fpage>3417</fpage><lpage>3425</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.9b05523</pub-id><pub-id pub-id-type="pmid">31970977</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Y-G</given-names></name><name><surname>TML</surname> <given-names>L</given-names></name><name><surname>Alam</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A simple, straightforward approach for generation of small, stable, homogeneous, unilamellar 1-palmitoyl 2-oleoyl phosphatidylcholine (POPC) bilayer vesicles</article-title><source>Bio-Protocol</source><volume>In press</volume></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Ortega</surname> <given-names>L</given-names></name><name><surname>Alegre-Cebollada</surname> <given-names>J</given-names></name><name><surname>García-Linares</surname> <given-names>S</given-names></name><name><surname>Bruix</surname> <given-names>M</given-names></name><name><surname>Martínez-del-Pozo</surname> <given-names>Álvaro</given-names></name><name><surname>Gavilanes</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The behavior of sea anemone actinoporins at the water–membrane interface</article-title><source>Biochimica Et Biophysica Acta (BBA) - Biomembranes</source><volume>1808</volume><fpage>2275</fpage><lpage>2288</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2011.05.012</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimmer</surname> <given-names>S</given-names></name><name><surname>Ying</surname> <given-names>M</given-names></name><name><surname>Wälchli</surname> <given-names>S</given-names></name><name><surname>van Deurs</surname> <given-names>B</given-names></name><name><surname>Sandvig</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Golgi vesiculation induced by cholesterol occurs by a dynamin- and cPLA2-dependent mechanism</article-title><source>Traffic</source><volume>6</volume><fpage>144</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00258.x</pub-id><pub-id pub-id-type="pmid">15634214</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Valero</surname> <given-names>M</given-names></name><name><surname>Ferrer-Orta</surname> <given-names>C</given-names></name><name><surname>Querol-Audí</surname> <given-names>J</given-names></name><name><surname>Marin-Vicente</surname> <given-names>C</given-names></name><name><surname>Fita</surname> <given-names>I</given-names></name><name><surname>Gómez-Fernández</surname> <given-names>JC</given-names></name><name><surname>Verdaguer</surname> <given-names>N</given-names></name><name><surname>Corbalán-García</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Structural and mechanistic insights into the association of PKCalpha-C2 domain to PtdIns(4,5)P2</article-title><source>PNAS</source><volume>106</volume><fpage>6603</fpage><lpage>6607</lpage><pub-id pub-id-type="doi">10.1073/pnas.0813099106</pub-id><pub-id pub-id-type="pmid">19346474</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillén</surname> <given-names>J</given-names></name><name><surname>Ferrer-Orta</surname> <given-names>C</given-names></name><name><surname>Buxaderas</surname> <given-names>M</given-names></name><name><surname>Pérez-Sánchez</surname> <given-names>D</given-names></name><name><surname>Guerrero-Valero</surname> <given-names>M</given-names></name><name><surname>Luengo-Gil</surname> <given-names>G</given-names></name><name><surname>Pous</surname> <given-names>J</given-names></name><name><surname>Guerra</surname> <given-names>P</given-names></name><name><surname>Gómez-Fernández</surname> <given-names>JC</given-names></name><name><surname>Verdaguer</surname> <given-names>N</given-names></name><name><surname>Corbalán-García</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural insights into the Ca2+ and PI(4,5)P2 binding modes of the C2 domains of rabphilin 3A and synaptotagmin 1</article-title><source>PNAS</source><volume>110</volume><fpage>20503</fpage><lpage>20508</lpage><pub-id pub-id-type="doi">10.1073/pnas.1316179110</pub-id><pub-id pub-id-type="pmid">24302762</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honigmann</surname> <given-names>A</given-names></name><name><surname>van den Bogaart</surname> <given-names>G</given-names></name><name><surname>Iraheta</surname> <given-names>E</given-names></name><name><surname>Risselada</surname> <given-names>HJ</given-names></name><name><surname>Milovanovic</surname> <given-names>D</given-names></name><name><surname>Mueller</surname> <given-names>V</given-names></name><name><surname>Müllar</surname> <given-names>S</given-names></name><name><surname>Diederichsen</surname> <given-names>U</given-names></name><name><surname>Fasshauer</surname> <given-names>D</given-names></name><name><surname>Grubmüller</surname> <given-names>H</given-names></name><name><surname>Hell</surname> <given-names>SW</given-names></name><name><surname>Eggeling</surname> <given-names>C</given-names></name><name><surname>Kühnel</surname> <given-names>K</given-names></name><name><surname>Jahn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Phosphatidylinositol 4,5-bisphosphate clusters act as molecular beacons for vesicle recruitment</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>20</volume><fpage>679</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2570</pub-id><pub-id pub-id-type="pmid">23665582</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>HW</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Cohen</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PC-TP/StARD2: of membranes and metabolism</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>21</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2010.02.001</pub-id><pub-id pub-id-type="pmid">20338778</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapisz</surname> <given-names>E</given-names></name><name><surname>Masliah</surname> <given-names>J</given-names></name><name><surname>Béréziat</surname> <given-names>G</given-names></name><name><surname>Wolf</surname> <given-names>C</given-names></name><name><surname>Koumanov</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A(2)</article-title><source>Journal of Lipid Research</source><volume>41</volume><fpage>1680</fpage><lpage>1688</lpage><pub-id pub-id-type="pmid">11013311</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovács</surname> <given-names>T</given-names></name><name><surname>Batta</surname> <given-names>G</given-names></name><name><surname>Zákány</surname> <given-names>F</given-names></name><name><surname>Szöllősi</surname> <given-names>J</given-names></name><name><surname>Nagy</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The dipole potential correlates with lipid raft markers in the plasma membrane of living cells</article-title><source>Journal of Lipid Research</source><volume>58</volume><fpage>1681</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1194/jlr.M077339</pub-id><pub-id pub-id-type="pmid">28607008</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname> <given-names>E</given-names></name><name><surname>Henrick</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>60</volume><fpage>2256</fpage><lpage>2268</lpage><pub-id pub-id-type="doi">10.1107/S0907444904026460</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamour</surname> <given-names>NF</given-names></name><name><surname>Subramanian</surname> <given-names>P</given-names></name><name><surname>Wijesinghe</surname> <given-names>DS</given-names></name><name><surname>Stahelin</surname> <given-names>RV</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name><name><surname>Chalfant</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>26897</fpage><lpage>26907</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.001677</pub-id><pub-id pub-id-type="pmid">19632995</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname> <given-names>MA</given-names></name><name><surname>Blackshields</surname> <given-names>G</given-names></name><name><surname>Brown</surname> <given-names>NP</given-names></name><name><surname>Chenna</surname> <given-names>R</given-names></name><name><surname>McGettigan</surname> <given-names>PA</given-names></name><name><surname>McWilliam</surname> <given-names>H</given-names></name><name><surname>Valentin</surname> <given-names>F</given-names></name><name><surname>Wallace</surname> <given-names>IM</given-names></name><name><surname>Wilm</surname> <given-names>A</given-names></name><name><surname>Lopez</surname> <given-names>R</given-names></name><name><surname>Thompson</surname> <given-names>JD</given-names></name><name><surname>Gibson</surname> <given-names>TJ</given-names></name><name><surname>Higgins</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Clustal W and clustal X version 2.0</article-title><source>Bioinformatics</source><volume>23</volume><fpage>2947</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id><pub-id pub-id-type="pmid">17846036</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>CC</given-names></name><name><surname>Gangelhoff</surname> <given-names>TA</given-names></name><name><surname>Gelb</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Localization and function of cytosolic phospholipase A2alpha at the Golgi</article-title><source>Biochimie</source><volume>92</volume><fpage>620</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2010.03.001</pub-id><pub-id pub-id-type="pmid">20226226</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cytosolic phospholipase A₂: physiological function and role in disease</article-title><source>Journal of Lipid Research</source><volume>56</volume><fpage>1386</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1194/jlr.R057588</pub-id><pub-id pub-id-type="pmid">25838312</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>CC</given-names></name><name><surname>Channon</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Anionic phospholipids stimulate an arachidonoyl-hydrolyzing phospholipase A2 from macrophages and reduce the calcium requirement for activity</article-title><source>Biochimica Et Biophysica Acta (BBA) - Lipids and Lipid Metabolism</source><volume>1045</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(90)90129-L</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Málková</surname> <given-names>S</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name><name><surname>Stahelin</surname> <given-names>RV</given-names></name><name><surname>Pingali</surname> <given-names>SV</given-names></name><name><surname>Murray</surname> <given-names>D</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name><name><surname>Schlossman</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>X-ray reflectivity studies of cPLA2{alpha}-C2 domains adsorbed onto Langmuir monolayers of SOPC</article-title><source>Biophysical Journal</source><volume>89</volume><fpage>1861</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1529/biophysj.105.061515</pub-id><pub-id pub-id-type="pmid">15994899</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmberg</surname> <given-names>NJ</given-names></name><name><surname>Van Buskirk</surname> <given-names>DR</given-names></name><name><surname>Falke</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Membrane-docking loops of the cPLA2 C2 domain: detailed structural analysis of the protein-membrane interface via site-directed spin-labeling</article-title><source>Biochemistry</source><volume>42</volume><fpage>13227</fpage><lpage>13240</lpage><pub-id pub-id-type="doi">10.1021/bi035119+</pub-id><pub-id pub-id-type="pmid">14609334</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmberg</surname> <given-names>NJ</given-names></name><name><surname>Falke</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Use of EPR power saturation to analyze the membrane-docking geometries of peripheral proteins: applications to C2 domains</article-title><source>Annual Review of Biophysics and Biomolecular Structure</source><volume>34</volume><fpage>71</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.34.040204.144534</pub-id><pub-id pub-id-type="pmid">15869384</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname> <given-names>TJ</given-names></name><name><surname>Simon</surname> <given-names>SA</given-names></name><name><surname>Needham</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Interbilayer interactions between sphingomyelin and sphingomyelin/cholesterol bilayers</article-title><source>Biochemistry</source><volume>31</volume><fpage>2020</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.1021/bi00122a018</pub-id><pub-id pub-id-type="pmid">1536845</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosior</surname> <given-names>M</given-names></name><name><surname>Six</surname> <given-names>DA</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>2184</fpage><lpage>2191</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.4.2184</pub-id><pub-id pub-id-type="pmid">9442060</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouchlis</surname> <given-names>VD</given-names></name><name><surname>Bucher</surname> <given-names>D</given-names></name><name><surname>McCammon</surname> <given-names>JA</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates</article-title><source>PNAS</source><volume>112</volume><fpage>E516</fpage><lpage>E525</lpage><pub-id pub-id-type="doi">10.1073/pnas.1424651112</pub-id><pub-id pub-id-type="pmid">25624474</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>H</given-names></name><name><surname>Wakita</surname> <given-names>S</given-names></name><name><surname>Suganami</surname> <given-names>A</given-names></name><name><surname>Tamura</surname> <given-names>Y</given-names></name><name><surname>Hanada</surname> <given-names>K</given-names></name><name><surname>Murayama</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin</article-title><source>Journal of Lipid Research</source><volume>51</volume><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1194/jlr.M002428</pub-id><pub-id pub-id-type="pmid">19965591</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalefski</surname> <given-names>EA</given-names></name><name><surname>Sultzman</surname> <given-names>LA</given-names></name><name><surname>Martin</surname> <given-names>DM</given-names></name><name><surname>Kriz</surname> <given-names>RW</given-names></name><name><surname>Towler</surname> <given-names>PS</given-names></name><name><surname>Knopf</surname> <given-names>JL</given-names></name><name><surname>Clark</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca<sup>2+</sup>)-dependent lipid-binding domain and a ca<sup>(2+</sup>)-independent catalytic domain</article-title><source>Journal of Biological Chemistry</source><volume>269</volume><fpage>18239</fpage><lpage>18249</lpage><pub-id pub-id-type="pmid">8027085</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalefski</surname> <given-names>EA</given-names></name><name><surname>McDonagh</surname> <given-names>T</given-names></name><name><surname>Somers</surname> <given-names>W</given-names></name><name><surname>Seehra</surname> <given-names>J</given-names></name><name><surname>Falke</surname> <given-names>JJ</given-names></name><name><surname>Clark</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>1365</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.3.1365</pub-id><pub-id pub-id-type="pmid">9430670</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalefski</surname> <given-names>EA</given-names></name><name><surname>Falke</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Location of the membrane-docking face on the Ca<sup>2+</sup>-activated C2 domain of cytosolic phospholipase A2</article-title><source>Biochemistry</source><volume>37</volume><fpage>17642</fpage><lpage>17650</lpage><pub-id pub-id-type="pmid">9922129</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochoa-Lizarralde</surname> <given-names>B</given-names></name><name><surname>Gao</surname> <given-names>YG</given-names></name><name><surname>Popov</surname> <given-names>AN</given-names></name><name><surname>Samygina</surname> <given-names>VR</given-names></name><name><surname>Zhai</surname> <given-names>X</given-names></name><name><surname>Mishra</surname> <given-names>SK</given-names></name><name><surname>Boldyrev</surname> <given-names>IA</given-names></name><name><surname>Molotkovsky</surname> <given-names>JG</given-names></name><name><surname>Simanshu</surname> <given-names>DK</given-names></name><name><surname>Patel</surname> <given-names>DJ</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name><name><surname>Malinina</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into sphingolipid recognition by the glycolipid transfer protein family</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>16709</fpage><lpage>16723</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.000733</pub-id><pub-id pub-id-type="pmid">30206120</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otwinowski</surname> <given-names>Z</given-names></name><name><surname>Minor</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Processing of X-ray diffraction data collected in oscillation mode</article-title><source>Methods in Enzymology</source><volume>276</volume><fpage>307</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">27754618</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perisic</surname> <given-names>O</given-names></name><name><surname>Fong</surname> <given-names>S</given-names></name><name><surname>Lynch</surname> <given-names>DE</given-names></name><name><surname>Bycroft</surname> <given-names>M</given-names></name><name><surname>Williams</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>1596</fpage><lpage>1604</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.3.1596</pub-id><pub-id pub-id-type="pmid">9430701</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettus</surname> <given-names>BJ</given-names></name><name><surname>Bielawska</surname> <given-names>A</given-names></name><name><surname>Subramanian</surname> <given-names>P</given-names></name><name><surname>Wijesinghe</surname> <given-names>DS</given-names></name><name><surname>Maceyka</surname> <given-names>M</given-names></name><name><surname>Leslie</surname> <given-names>CC</given-names></name><name><surname>Evans</surname> <given-names>JH</given-names></name><name><surname>Freiberg</surname> <given-names>J</given-names></name><name><surname>Roddy</surname> <given-names>P</given-names></name><name><surname>Hannun</surname> <given-names>YA</given-names></name><name><surname>Chalfant</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>11320</fpage><lpage>11326</lpage><pub-id pub-id-type="doi">10.1074/jbc.M309262200</pub-id><pub-id pub-id-type="pmid">14676210</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>CS</given-names></name><name><surname>Chung</surname> <given-names>T</given-names></name><name><surname>Pike</surname> <given-names>HM</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Glycolipid transfer protein interaction with bilayer vesicles: modulation by changing lipid composition</article-title><source>Biophysical Journal</source><volume>89</volume><fpage>4017</fpage><lpage>4028</lpage><pub-id pub-id-type="doi">10.1529/biophysj.105.070631</pub-id><pub-id pub-id-type="pmid">16169991</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richens</surname> <given-names>JL</given-names></name><name><surname>Lane</surname> <given-names>JS</given-names></name><name><surname>Bramble</surname> <given-names>JP</given-names></name><name><surname>O'Shea</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The electrical interplay between proteins and lipids in membranes</article-title><source>Biochimica et Biophysica Acta (BBA) - Biomembranes</source><volume>1848</volume><fpage>1828</fpage><lpage>1836</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2015.03.017</pub-id><pub-id pub-id-type="pmid">25817548</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname> <given-names>J</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>C2-domains, structure and function of a universal Ca<sup>2+</sup>-binding domain</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>15879</fpage><lpage>15882</lpage><pub-id pub-id-type="pmid">9632630</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roderick</surname> <given-names>SL</given-names></name><name><surname>Chan</surname> <given-names>WW</given-names></name><name><surname>Agate</surname> <given-names>DS</given-names></name><name><surname>Olsen</surname> <given-names>LR</given-names></name><name><surname>Vetting</surname> <given-names>MW</given-names></name><name><surname>Rajashankar</surname> <given-names>KR</given-names></name><name><surname>Cohen</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structure of human phosphatidylcholine transfer protein in complex with its ligand</article-title><source>Nature Structural Biology</source><volume>9</volume><fpage>507</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nsb812</pub-id><pub-id pub-id-type="pmid">12055623</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>San Pietro</surname> <given-names>E</given-names></name><name><surname>Capestrano</surname> <given-names>M</given-names></name><name><surname>Polishchuk</surname> <given-names>EV</given-names></name><name><surname>DiPentima</surname> <given-names>A</given-names></name><name><surname>Trucco</surname> <given-names>A</given-names></name><name><surname>Zizza</surname> <given-names>P</given-names></name><name><surname>Mariggiò</surname> <given-names>S</given-names></name><name><surname>Pulvirenti</surname> <given-names>T</given-names></name><name><surname>Sallese</surname> <given-names>M</given-names></name><name><surname>Tete</surname> <given-names>S</given-names></name><name><surname>Mironov</surname> <given-names>AA</given-names></name><name><surname>Leslie</surname> <given-names>CC</given-names></name><name><surname>Corda</surname> <given-names>D</given-names></name><name><surname>Luini</surname> <given-names>A</given-names></name><name><surname>Polishchuk</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Group IV phospholipase A(2)alpha controls the formation of inter-cisternal continuities involved in intra-Golgi transport</article-title><source>PLoS Biology</source><volume>7</volume><elocation-id>e1000194</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000194</pub-id><pub-id pub-id-type="pmid">19753100</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaaf</surname> <given-names>G</given-names></name><name><surname>Ortlund</surname> <given-names>EA</given-names></name><name><surname>Tyeryar</surname> <given-names>KR</given-names></name><name><surname>Mousley</surname> <given-names>CJ</given-names></name><name><surname>Ile</surname> <given-names>KE</given-names></name><name><surname>Garrett</surname> <given-names>TA</given-names></name><name><surname>Ren</surname> <given-names>J</given-names></name><name><surname>Woolls</surname> <given-names>MJ</given-names></name><name><surname>Raetz</surname> <given-names>CR</given-names></name><name><surname>Redinbo</surname> <given-names>MR</given-names></name><name><surname>Bankaitis</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily</article-title><source>Molecular Cell</source><volume>29</volume><fpage>191</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.11.026</pub-id><pub-id pub-id-type="pmid">18243114</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname> <given-names>X</given-names></name><name><surname>Fernandez</surname> <given-names>I</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name><name><surname>Rizo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Solution structures of the Ca<sup>2+</sup>-free and Ca<sup>2+</sup>-bound C2A domain of synaptotagmin I: does Ca<sup>2+</sup> induce a conformational change?</article-title><source>Biochemistry</source><volume>37</volume><fpage>16106</fpage><lpage>16115</lpage><pub-id pub-id-type="doi">10.1021/bi981789h</pub-id><pub-id pub-id-type="pmid">9819203</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T</given-names></name><name><surname>Ohto</surname> <given-names>T</given-names></name><name><surname>Kita</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cytosolic phospholipase A2: biochemical properties and physiological roles</article-title><source>IUBMB Life</source><volume>58</volume><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1080/15216540600702289</pub-id><pub-id pub-id-type="pmid">16754327</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Six</surname> <given-names>DA</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Essential ca<sup>(2+)</sup>-independent role of the group IVA cytosolic phospholipase A(2) C2 domain for interfacial activity</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>23842</fpage><lpage>23850</lpage><pub-id pub-id-type="doi">10.1074/jbc.M301386200</pub-id><pub-id pub-id-type="pmid">12672805</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotte</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The importance of hydrogen bonding in Sphingomyelin's membrane interactions with co-lipids</article-title><source>Biochimica Et Biophysica Acta (BBA) - Biomembranes</source><volume>1858</volume><fpage>304</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2015.12.008</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smaby</surname> <given-names>JM</given-names></name><name><surname>Kulkarni</surname> <given-names>VS</given-names></name><name><surname>Momsen</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The interfacial elastic packing interactions of Galactosylceramides, sphingomyelins, and phosphatidylcholines</article-title><source>Biophysical Journal</source><volume>70</volume><fpage>868</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(96)79629-7</pub-id><pub-id pub-id-type="pmid">8789104</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>WL</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The eicosanoids and their biochemical mechanisms of action</article-title><source>Biochemical Journal</source><volume>259</volume><fpage>315</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1042/bj2590315</pub-id><pub-id pub-id-type="pmid">2655580</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahelin</surname> <given-names>RV</given-names></name><name><surname>Subramanian</surname> <given-names>P</given-names></name><name><surname>Vora</surname> <given-names>M</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name><name><surname>Chalfant</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>20467</fpage><lpage>20474</lpage><pub-id pub-id-type="doi">10.1074/jbc.M701396200</pub-id><pub-id pub-id-type="pmid">17472963</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahelin</surname> <given-names>RV</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2001">2001a</year><article-title>Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2</article-title><source>Biochemistry</source><volume>40</volume><fpage>4672</fpage><lpage>4678</lpage><pub-id pub-id-type="doi">10.1021/bi0020325</pub-id><pub-id pub-id-type="pmid">11294634</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahelin</surname> <given-names>RV</given-names></name><name><surname>Cho</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2001">2001b</year><article-title>Roles of calcium ions in the membrane binding of C2 domains</article-title><source>Biochemical Journal</source><volume>359</volume><fpage>679</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1042/bj3590679</pub-id><pub-id pub-id-type="pmid">11672443</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tafesse</surname> <given-names>FG</given-names></name><name><surname>Huitema</surname> <given-names>K</given-names></name><name><surname>Hermansson</surname> <given-names>M</given-names></name><name><surname>van der Poel</surname> <given-names>S</given-names></name><name><surname>van den Dikkenberg</surname> <given-names>J</given-names></name><name><surname>Uphoff</surname> <given-names>A</given-names></name><name><surname>Somerharju</surname> <given-names>P</given-names></name><name><surname>Holthuis</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>17537</fpage><lpage>17547</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702423200</pub-id><pub-id pub-id-type="pmid">17449912</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname> <given-names>DE</given-names></name><name><surname>Ghosh</surname> <given-names>M</given-names></name><name><surname>Ghomashchi</surname> <given-names>F</given-names></name><name><surname>Loper</surname> <given-names>R</given-names></name><name><surname>Suram</surname> <given-names>S</given-names></name><name><surname>John</surname> <given-names>BS</given-names></name><name><surname>Girotti</surname> <given-names>M</given-names></name><name><surname>Bollinger</surname> <given-names>JG</given-names></name><name><surname>Gelb</surname> <given-names>MH</given-names></name><name><surname>Leslie</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>9596</fpage><lpage>9611</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807299200</pub-id><pub-id pub-id-type="pmid">19176526</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uozumi</surname> <given-names>N</given-names></name><name><surname>Kume</surname> <given-names>K</given-names></name><name><surname>Nagase</surname> <given-names>T</given-names></name><name><surname>Nakatani</surname> <given-names>N</given-names></name><name><surname>Ishii</surname> <given-names>S</given-names></name><name><surname>Tashiro</surname> <given-names>F</given-names></name><name><surname>Komagata</surname> <given-names>Y</given-names></name><name><surname>Maki</surname> <given-names>K</given-names></name><name><surname>Ikuta</surname> <given-names>K</given-names></name><name><surname>Ouchi</surname> <given-names>Y</given-names></name><name><surname>Miyazaki</surname> <given-names>J</given-names></name><name><surname>Shimizu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Role of cytosolic phospholipase A2 in allergic response and parturition</article-title><source>Nature</source><volume>390</volume><fpage>618</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1038/37622</pub-id><pub-id pub-id-type="pmid">9403692</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasquez</surname> <given-names>AM</given-names></name><name><surname>Mouchlis</surname> <given-names>VD</given-names></name><name><surname>Dennis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Review of four major distinct types of human phospholipase A<sub>2</sub></article-title><source>Advances in Biological Regulation</source><volume>67</volume><fpage>212</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.jbior.2017.10.009</pub-id><pub-id pub-id-type="pmid">29248300</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdaguer</surname> <given-names>N</given-names></name><name><surname>Corbalan-Garcia</surname> <given-names>S</given-names></name><name><surname>Ochoa</surname> <given-names>WF</given-names></name><name><surname>Fita</surname> <given-names>I</given-names></name><name><surname>Gómez-Fernández</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ca<sup>(2+</sup>) bridges the C2 membrane-binding domain of protein kinase calpha directly to phosphatidylserine</article-title><source>The EMBO Journal</source><volume>18</volume><fpage>6329</fpage><lpage>6338</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.22.6329</pub-id><pub-id pub-id-type="pmid">10562545</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Klein</surname> <given-names>MG</given-names></name><name><surname>Snell</surname> <given-names>G</given-names></name><name><surname>Lane</surname> <given-names>W</given-names></name><name><surname>Zou</surname> <given-names>H</given-names></name><name><surname>Levin</surname> <given-names>I</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Sang</surname> <given-names>BC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure of human GIVD cytosolic phospholipase A2 reveals insights into substrate recognition</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>2769</fpage><lpage>2779</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.05.012</pub-id><pub-id pub-id-type="pmid">27220631</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>KE</given-names></name><name><surname>Ropa</surname> <given-names>JP</given-names></name><name><surname>Adu-Gyamfi</surname> <given-names>E</given-names></name><name><surname>Stahelin</surname> <given-names>RV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>C2 domain membrane penetration by group IVA cytosolic phospholipase A₂ induces membrane curvature changes</article-title><source>Journal of Lipid Research</source><volume>53</volume><fpage>2656</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1194/jlr.M030718</pub-id><pub-id pub-id-type="pmid">22991194</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname> <given-names>KE</given-names></name><name><surname>Bhardwaj</surname> <given-names>N</given-names></name><name><surname>Vora</surname> <given-names>M</given-names></name><name><surname>Chalfant</surname> <given-names>CE</given-names></name><name><surname>Lu</surname> <given-names>H</given-names></name><name><surname>Stahelin</surname> <given-names>RV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The molecular basis of ceramide-1-phosphate recognition by C2 domains</article-title><source>Journal of Lipid Research</source><volume>54</volume><fpage>636</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1194/jlr.M031088</pub-id><pub-id pub-id-type="pmid">23277511</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiener</surname> <given-names>MC</given-names></name><name><surname>White</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Structure of a fluid dioleoylphosphatidylcholine bilayer determined by joint refinement of x-ray and neutron diffraction data. III. complete structure</article-title><source>Biophysical Journal</source><volume>61</volume><fpage>434</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(92)81849-0</pub-id><pub-id pub-id-type="pmid">1547331</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijesinghe</surname> <given-names>DS</given-names></name><name><surname>Subramanian</surname> <given-names>P</given-names></name><name><surname>Lamour</surname> <given-names>NF</given-names></name><name><surname>Gentile</surname> <given-names>LB</given-names></name><name><surname>Granado</surname> <given-names>MH</given-names></name><name><surname>Bielawska</surname> <given-names>A</given-names></name><name><surname>Szulc</surname> <given-names>Z</given-names></name><name><surname>Gomez-Munoz</surname> <given-names>A</given-names></name><name><surname>Chalfant</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects</article-title><source>Journal of Lipid Research</source><volume>50</volume><fpage>1986</fpage><lpage>1995</lpage><pub-id pub-id-type="doi">10.1194/jlr.M800367-JLR200</pub-id><pub-id pub-id-type="pmid">19075030</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>GY</given-names></name><name><surname>McDonagh</surname> <given-names>T</given-names></name><name><surname>Yu</surname> <given-names>HA</given-names></name><name><surname>Nalefski</surname> <given-names>EA</given-names></name><name><surname>Clark</surname> <given-names>JD</given-names></name><name><surname>Cumming</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2</article-title><source>Journal of Molecular Biology</source><volume>280</volume><fpage>485</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1998.1874</pub-id><pub-id pub-id-type="pmid">9665851</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>X</given-names></name><name><surname>Boldyrev</surname> <given-names>IA</given-names></name><name><surname>Mizuno</surname> <given-names>NK</given-names></name><name><surname>Momsen</surname> <given-names>MM</given-names></name><name><surname>Molotkovsky</surname> <given-names>JG</given-names></name><name><surname>Brockman</surname> <given-names>HL</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nanoscale packing differences in sphingomyelin and phosphatidylcholine revealed by BODIPY fluorescence in monolayers: physiological implications</article-title><source>Langmuir</source><volume>30</volume><fpage>3154</fpage><lpage>3164</lpage><pub-id pub-id-type="doi">10.1021/la4047098</pub-id><pub-id pub-id-type="pmid">24564829</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>X</given-names></name><name><surname>Gao</surname> <given-names>YG</given-names></name><name><surname>Mishra</surname> <given-names>SK</given-names></name><name><surname>Simanshu</surname> <given-names>DK</given-names></name><name><surname>Boldyrev</surname> <given-names>IA</given-names></name><name><surname>Benson</surname> <given-names>LM</given-names></name><name><surname>Bergen</surname> <given-names>HR</given-names></name><name><surname>Malinina</surname> <given-names>L</given-names></name><name><surname>Mundy</surname> <given-names>J</given-names></name><name><surname>Molotkovsky</surname> <given-names>JG</given-names></name><name><surname>Patel</surname> <given-names>DJ</given-names></name><name><surname>Brown</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phosphatidylserine stimulates ceramide 1-Phosphate (C1P) Intermembrane transfer by C1P transfer proteins</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>2531</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.760256</pub-id><pub-id pub-id-type="pmid">28011644</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zizza</surname> <given-names>P</given-names></name><name><surname>Iurisci</surname> <given-names>C</given-names></name><name><surname>Bonazzi</surname> <given-names>M</given-names></name><name><surname>Cossart</surname> <given-names>P</given-names></name><name><surname>Leslie</surname> <given-names>CC</given-names></name><name><surname>Corda</surname> <given-names>D</given-names></name><name><surname>Mariggiò</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phospholipase A2IVα regulates phagocytosis independent of its enzymatic activity</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>16849</fpage><lpage>16859</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.309419</pub-id><pub-id pub-id-type="pmid">22393044</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.44760.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Radhakrishnan</surname><given-names>Arun</given-names></name><role>Reviewing Editor</role><aff><institution>University of Texas Southwestern Medical Center</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Structural basis of phosphatidylcholine recognition by the C2-domain of cytosolic phospholipase A<sub>2</sub>α&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Cynthia Wolberger as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>This study reports structural data which explains the selective binding of phosphatidylcholine (PC) to the C2 domain of cytosolic phospholipase A<sub>2</sub>α (cPLA<sub>2</sub>). The data reveal the positioning of the bound PC headgroup and identify a novel calcium bridge between cPLA<sub>2</sub>'s C2 and PC's phosphoryl group. This study improves our understanding of how calcium and lipid coordination can be mediated in different ways in C2 domains of different proteins. The reviewers all agreed that the data were of high quality and that the findings were significant, but also raised some points that need to be addressed.</p><p>Essential revisions:</p><p>1) Please address the following questions about PC selectivity:</p><p>The positively charged choline headgroup of PC appears to lie near the positive calcium charge of Ca1. Is it possibly more favorable to have anionic lipid here (PS due to size or even PE due to size/shape)? The authors discuss this in Figure 4—figure supplement 1 by showing different lipid structures and discussing why they may or may not bind compared to PC.</p><p>But, could the new structure here actually be revealing something more? Since PC has been studied as the bulk lipid that binds and PC was used to crystallize, perhaps the field has been biased against lipid mixtures (with small anionic lipid such as PS or other in the vesicles)?</p><p>The authors suggest PS will have some repulsions due to the anionic headgroup but it is difficult to see this. Also, the phosphoryl group of anionic lipid could be stabilized by the calcium bound to the C2 domain.</p><p>Similarly, the PC headgroup is close to His62, which under some conditions could be partially protonated (~pKa near 6).</p><p>2) As written, the reduction in binding and/or activity by Y96A or N65D doesn't really prove they are involved in PC selectivity, it just demonstrated mutations reduce affinity and activity. To prove/demonstrate selectivity, one would have to compare the mutants and WT to lipids under these different conditions. The authors may want to consider rephrasing/rewriting these statements based upon their findings and that of the previous literature. For instance, although SM binding is low, what would the effects of mutations be? Would there be selective reduction in PC binding vs. that of SM?</p><p>Also, the SM vs. PC comparison is good and the authors are right that it hasn't been addressed much before. That being said, is SM relevant for Golgi or ER targeting of cPLA<sub>2</sub> vs. that of PC or other lipids?</p><p>3) Please address the following points regarding previous work in the field:</p><p>The Introduction (paragraph three) points out that the lack of a lipid-bound crystal form of the C2 domain has hampered understanding of the structural basis of lipid activation mechanisms. While this current study does provide the lipid-bound structure to advance the field, it may be worth pointing out how the work of Ed Dennis and colleagues (among others) using molecular dynamics and hydrogen-deuterium exchange mass spectrometry has helped the field in understanding cPLA<sub>2</sub> activity.</p><p>More details should be incorporated on the work done on Y96A and N65A by Bittova et al., 1999, as well as the role of N65A in membrane binding and penetration by Stahelin and Cho, 2001. and work by Burke et al. 2008. Bittova et al. studied the Y96A effects in full-length cPLA<sub>2</sub> demonstrating a reduction in affinity for DHPC and a reduction in activity, which is confirmed in the current study. Similarly, it was shown that N65A reduced cPLA<sub>2</sub> DHPC affinity and enzyme activity.</p><p>4) Were the studies with full-length protein pursued with rat, human or chicken cPLA<sub>2</sub>? If not chicken, can the C2 chicken structure and lipid binding be directly compared to its influence on the C2-catalytic role in rat or human? If full-length chicken cPLA<sub>2</sub> was used, how does its catalytic domain sequence compare to rat and human, and how does its activity compare to those published previously for the rat or human enzymes?</p><p>Classically, the C2 domain of cPLA<sub>2</sub> (rat) needed to be refolded from <italic>E. coli</italic> expression due to solubility issues. The authors have made great strides here in expressing the C2 domain from chicken cPLA<sub>2</sub> in soluble form. This could be of interest to the field so a bit more detail on this solubility in the Materials and methods would be useful.</p><p>It would be helpful to have the alignment of the full cPLA<sub>2</sub> of chicken with rat and human species.</p><p>5) In Figure 5, where the authors model the crystal structure onto the schematic drawing and compare to EPR results, it would be more informative if distances are compared. For example, distances from x-ray structure, headgroup dimensions, EPR data can be compared. How deep in the membrane does the C2 domain go from experimental studies?</p><p>6) The binding of DHPC in one site is well appreciated but it is expected that the C2 domain will make contact and interact (at least non-specifically) with a number of lipid head groups around CBLs 1 and 3. Can this briefly be incorporated into the discussion model?</p><p>Also, in the crystal lattice, do the hydrophobic side chains of the lipid molecule interact with each other?</p><p>7) Synaptotagmin 1 C2A domain binds to three calcium ions. Can the authors comment and compare the structures?</p><p>8) In the Materials and methods, the authors mention C1P purchased from Avanti but it is not clear when or how they were used in the paper? In crystallization attempts?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.44760.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please address the following questions about PC selectivity:</p><p>The positively charged choline headgroup of PC appears to lie near the positive calcium charge of Ca1.</p></disp-quote><p>Admittedly, the viewing angles presented for the C2-domain/DHPC complex are not very clear about the distance between Ca1 and the choline headgroup of PC. To clarify this issue, we have now added the distances between Ca1 and the DHPC choline nitrogen (5.5 Å) and between Ca1 and the DHPC phosphate (5.7 Å) to Table 1. Such distances are not indicative of interactions.</p><disp-quote content-type="editor-comment"><p>Is it possibly more favorable to have anionic lipid here (PS due to size or even PE due to size/shape)? The authors discuss this in Figure 4—figure supplement 1 by showing different lipid structures and discussing why they may or may not bind compared to PC.</p><p>But, could the new structure here actually be revealing something more? Since PC has been studied as the bulk lipid that binds and PC was used to crystallize, perhaps the field has been biased against lipid mixtures (with small anionic lipid such as PS or other in the vesicles)?</p><p>The authors suggest PS will have some repulsions due to the anionic headgroup but it is difficult to see this. Also, the phosphoryl group of anionic lipid could be stabilized by the calcium bound to the C2 domain.</p></disp-quote><p>To better illustrate the situation, we have revised Figure 2 by replacing panel C with a new space-filling rendition showing the C2-domain contacts that provide the especially ‘good fit’ for the phosphorylcholine headgroup of bound DHPC. The original panel C of Figure 2 has been incorporated into Figure 2—figure supplement 1. Moreover, we carried out additional new SPR experiments using wild-type C2-domain and vesicles composed of various phosphoglycerides including PS. The new data, which are now included in Figure 4, clearly show weak interaction by cPLA<sub>2</sub>α C2-domain for POPS, POPA, POPG, and POPI compared to POPC (subsection “Lipid specificity of cPLA<sub>2</sub>α C2-domian”). Unfortunately, technical problems prevented acquisition of reliable data for pure POPE as explained in the text. To circumvent the pure POPE problem, this lipid was mixed with POPS or POPC to assess the effect on C2-domain interaction. Whereas no interaction of PE could be detected in the presence of PC, a weak positive response was elicited in the presence of PS. Our findings are supported by earlier studies of refolded cPLA<sub>2</sub>α C-domain by Nalfeski et al., 1998, who reported strong binding to PC, but much weaker binding to vesicles composed of POPS and various other phosphoglycerides (POPG, POPA, mixed acyl PI, and POPE) using FRET and sedimentation assays.</p><disp-quote content-type="editor-comment"><p>Similarly, the PC headgroup is close to His62, which under some conditions could be partially protonated (~pKa near 6).</p></disp-quote><p>His62 appears to be sufficiently close for van der Waals contacts with the choline methyl groups. We initially suspected that His62 might be able to undergo weak cation-π interaction to the choline moiety (~ 5.0 Å). However, Ward et al., 2013, reported only slight differences in the binding of wild-type and H62A C2-domain to POPC vesicles using SPR. In this same study, changes in pH (6.0, 7.4, and 8.0) reportedly had no effect on binding to C2-domain to POPC vesicles. To clarify the situation, we have modified and added text along with the Ward et al., 2013, reference.</p><disp-quote content-type="editor-comment"><p>2) As written, the reduction in binding and/or activity by Y96A or N65D doesn't really prove they are involved in PC selectivity, it just demonstrated mutations reduce affinity and activity. To prove/demonstrate selectivity, one would have to compare the mutants and WT to lipids under these different conditions. The authors may want to consider rephrasing/rewriting these statements based upon their findings and that of the previous literature. For instance, although SM binding is low, what would the effects of mutations be? Would there be selective reduction in PC binding vs. that of SM?</p></disp-quote><p>We agree with the concern raised by the reviewer. We performed the suggested experiment involving testing of the mutants and WT with the sphingomyelin vesicles by SPR and have included the new results in Figure 4 (panel 4D). The data show that the relative changes in binding to POPC and 18:1-SM for WT and mutant C2-domains are similar (within experimental error) and modified the text accordingly (subsection “Lipid specificity of cPLA<sub>2</sub>α C2-domain”). We also have modified text by rephrasing to ‘phosphorylcholine headgroup lipids’ where needed.</p><disp-quote content-type="editor-comment"><p>Also, the SM vs. PC comparison is good and the authors are right that it hasn't been addressed much before. That being said, is SM relevant for Golgi or ER targeting of cPLA<sub>2</sub> vs. that of PC or other lipids?</p></disp-quote><p>We have added new text providing information about the in vivo location of SM in the Golgi and the expected minimal impact on cPLA<sub>2</sub>α action (subsection “Lipid specificity of cPLA<sub>2</sub>α C2-domain” paragraph five).</p><disp-quote content-type="editor-comment"><p>3) Please address the following points regarding previous work in the field:</p><p>The Introduction (paragraph three) points out that the lack of a lipid-bound crystal form of the C2 domain has hampered understanding of the structural basis of lipid activation mechanisms. While this current study does provide the lipid-bound structure to advance the field, it may be worth pointing out how the work of Ed Dennis and colleagues (among others) using molecular dynamics and hydrogen-deuterium exchange mass spectrometry has helped the field in understanding cPLA<sub>2</sub> activity.</p></disp-quote><p>We agree with the recommendation and have added new text (Introduction paragraph four) as well as the relevant references (Burke et al., 2008; Cao et al., 2013; Mouchlisa et al., 2015) to improve the situation.</p><disp-quote content-type="editor-comment"><p>More details should be incorporated on the work done on Y96A and N65A by Bittova et al., 1999, as well as the role of N65A in membrane binding and penetration by Stahelin and Cho, 2001, and work by Burke et al. 2008, Bittova et al. studied the Y96A effects in full-length cPLA<sub>2</sub> demonstrating a reduction in affinity for DHPC and a reduction in activity, which is confirmed in the current study. Similarly, it was shown that N65A reduced cPLA<sub>2</sub> DHPC affinity and enzyme activity.</p></disp-quote><p>We agree with the recommendation and have added new text (Introduction paragraph two) as well as the relevant references (Bittova et al., 1999; Stahelin and Cho, 2001) to improve the situation. Also, new text is now modified and added to the beginning of the Discussion paragraph one.</p><disp-quote content-type="editor-comment"><p>4) Were the studies with full-length protein pursued with rat, human or chicken cPLA<sub>2</sub>? If not chicken, can the C2 chicken structure and lipid binding be directly compared to its influence on the C2-catalytic role in rat or human? If full-length chicken cPLA<sub>2</sub> was used, how does its catalytic domain sequence compare to rat and human, and how does its activity compare to those published previously for the rat or human enzymes?</p></disp-quote><p>Clarifying text has been added to the Figure 3 legend. We also have included a new figure (Figure 1—figure supplement 1) showing the sequence alignment of the full-length cPLA<sub>2</sub> of chicken, mouse, and human species. The very highly homologous nature of the sequences strongly suggests similar outcomes regardless of the species used.</p><disp-quote content-type="editor-comment"><p>Classically, the C2 domain of cPLA<sub>2</sub> (rat) needed to be refolded from E. coli expression due to solubility issues. The authors have made great strides here in expressing the C2 domain from chicken cPLA<sub>2</sub> in soluble form. This could be of interest to the field so a bit more detail on this solubility in the Materials and methods would be useful.</p></disp-quote><p>We thank the reviewer for acknowledging the technical advance that has accompanied our structural data. We have provided additional new text in the Materials and methods section. This new text describes the technical details associated with the development of C2-domain clones that can be expressed in soluble form in <italic>E. coli</italic>.</p><disp-quote content-type="editor-comment"><p>It would be helpful to have the alignment of the full cPLA<sub>2</sub> of chicken with rat and human species.</p><p>5) In Figure 5, where the authors model the crystal structure onto the schematic drawing and compare to EPR results, it would be more informative if distances are compared. For example, distances from x-ray structure, headgroup dimensions, EPR data can be compared. How deep in the membrane does the C2 domain go from experimental studies?</p></disp-quote><p>We agree and have now added the information regarding distances from the X-ray structure to the text describing the ad hoc model. We also discuss the C2-domain penetration depth within the context of liquid-crystalline bilayer structural information reported by Wiener and White, 1992. We find agreement with previously published penetration distances into the bilayer for Val97 and Ile39. The new text is now added in paragraph two of the Discussion section.</p><disp-quote content-type="editor-comment"><p>6) The binding of DHPC in one site is well appreciated but it is expected that the C2 domain will make contact and interact (at least non-specifically) with a number of lipid head groups around CBLs 1 and 3. Can this briefly be incorporated into the discussion model?</p></disp-quote><p>We have now incorporated this kind of descriptive text at the start of the Discussion section.</p><disp-quote content-type="editor-comment"><p>Also, in the crystal lattice, do the hydrophobic side chains of the lipid molecule interact with each other?</p></disp-quote><p>We have added information to the legend of Figure 1—figure supplement 2 (which shows the crystal packing lattice of the cPLA<sub>2</sub> C2-domain/DHPC structural complex. The new information describes the distances associated between the acyl chains of the bound DHPC in the complexes. For comparison, we also have added the differing crystal packing lattice for lipid free C2-domain (PDB: 1RWL) as a new lower panel and referred to this new information in paragraph three of the Discussion section.</p><disp-quote content-type="editor-comment"><p>7) Synaptotagmin 1 C2A domain binds to three calcium ions. Can the authors comment and compare the structures?</p></disp-quote><p>Now included as Figure 6—figure supplement 1 is a direct structural comparison</p><p>(superpositioning) of the C2A domain of synaptotagmin-1 and the cPLA<sub>2</sub>α C-domain. The figure and associated legend, which provide a clear indication of differences and similarities with regards to Ca<sup>2+</sup> binding, are pointed out in the Discussion subsection “Comparison of PL recognition with other C2–domains” paragraph three.</p><disp-quote content-type="editor-comment"><p>8) In the Materials and methods, the authors mention C1P purchased from Avanti but it is not clear when or how they were used in the paper? In crystallization attempts?</p></disp-quote><p>At the beginning of the Results, we briefly mentioned attempting to generate C2-domain complexes with various lipids including PC, related phosphoglycerides and C1P analogs.</p></body></sub-article></article>